WO2012129847A1 - Methods for simultaneously determinating multi-component of simotang and fingerprint building method thereof - Google Patents

Methods for simultaneously determinating multi-component of simotang and fingerprint building method thereof Download PDF

Info

Publication number
WO2012129847A1
WO2012129847A1 PCT/CN2011/075808 CN2011075808W WO2012129847A1 WO 2012129847 A1 WO2012129847 A1 WO 2012129847A1 CN 2011075808 W CN2011075808 W CN 2011075808W WO 2012129847 A1 WO2012129847 A1 WO 2012129847A1
Authority
WO
WIPO (PCT)
Prior art keywords
tang
preparation
fingerprint
column
mobile phase
Prior art date
Application number
PCT/CN2011/075808
Other languages
French (fr)
Chinese (zh)
Inventor
易跃能
刘令安
王长虹
程雪梅
杨华
邓义德
刘东文
Original Assignee
湖南汉森制药股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 湖南汉森制药股份有限公司 filed Critical 湖南汉森制药股份有限公司
Publication of WO2012129847A1 publication Critical patent/WO2012129847A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8675Evaluation, i.e. decoding of the signal into analytical information
    • G01N30/8686Fingerprinting, e.g. without prior knowledge of the sample components
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/50Conditioning of the sorbent material or stationary liquid

Definitions

  • the invention relates to a method for simultaneously determining a multi-index component of a Si Mo Tang preparation, and a method for constructing a fingerprint of a Si Mo Tang preparation. Background technique
  • the four-bred Chinese medicine includes four kinds of herbs: woody, oyster shell, black peony and betel nut.
  • the side has the effect of reducing qi and reducing the pain, eliminating the pain and eliminating pain. It can be used for infants and young children with milk stagnation syndrome (see bloating, abdominal pain, crying, anorexia, diarrhea or constipation), middle-aged qi stagnation, food dysfunction (certificate) See abdominal fullness, abdominal pain, constipation), and the recovery of gastrointestinal function after abdominal surgery.
  • milk stagnation syndrome see bloating, abdominal pain, crying, anorexia, diarrhea or constipation
  • middle-aged qi stagnation food dysfunction
  • food dysfunction certificate
  • Si Mo Tang preparation In the prior art, according to the traditional Chinese medicine prescription of Si Mo Tang, various preparations of the Si Mo Tang preparation have been prepared.
  • the usual preparation process is generally as follows: The four kinds of original medicinal materials are extracted by steam distillation to extract the aromatic water, and the aromatic water is enriched in the volatile oil, and then directly used or packaged for later use, and then the slag is extracted with water to obtain an aqueous extract, and the water is extracted.
  • the liquid can be concentrated and dried to obtain a dry paste powder, and the above-mentioned aromatic water or volatile oil, as well as an aqueous extract or a dry paste powder, and an appropriate auxiliary material is selected, thereby preparing an oral liquid, a dropping pill, an emulsifier, a capsule, a soft capsule, a tablet, A variety of dosage forms such as granules.
  • Chinese Patent No. 94110842.2 (Publication No. CN1106288) discloses a four-mill soup mouth liquid. It adopts Chinese traditional medicine betel nut 10 ⁇ 25%, woody incense 10 ⁇ 25%, oyster shell 20 ⁇ 30%, black peony 20 ⁇ 30%, take the above-mentioned medicinal herbs to extract aromatic components, and save; the slag is added with water to cook, and the filtrate is combined. , Concentrate, add ethanol to stand, filter the clear liquid, recover the ethanol under reduced pressure, add water to boil, filter to remove the residue, add the aromatic component water and appropriate amount of auxiliary materials to the filtrate, filter, dispense and sterilize.
  • the four-mill soup includes betel nut, woody, clam shell and black peony.
  • the ingredients are complex and diverse.
  • the main components of woody agaric include acarids, alkaloids, body and amino acids
  • the main components of the clam shell include flavonoid glycosides.
  • Olefin and alkaloids the main components of black peony include steroids and alkaloids
  • the main components of betel nut include alkaloids, tannins and amino acids.
  • the existing quality standard of Si Mo Tang Oral Liquid is the Ministry of Standards WS-10040 (ZD-0040) -2002.
  • the standard "identification" item uses TLC method to identify woody and betel nut: Take the finished product of Si Mo Tang Oral Liquid, The organic solvent is used for extraction, and is prepared into a test solution after pretreatment; the reference drug is extracted with a suitable organic solvent, and is prepared into a reference drug solution after pretreatment; the test solution and the reference drug solution are plated on a thin layer of silica gel G. The plate is developed with a suitable developing agent, and the coloring agent is developed to identify the medicine.
  • Content determination item was determined by high performance liquid chromatography with the content of naringin as an indicator: octadecyl silicon germanium bonded silica as a filler; methanol-1% acetic acid (38: 62) as mobile phase; detection wavelength It is 283 nm.
  • the finished product of Si Mo Tang Oral Liquid is eluted by D 1Q1 macroporous adsorption resin column, and the eluent is collected to prepare a test solution; the reference substance of naringin is prepared as a reference solution; the naringin is calculated by external standard method content. This standard does not quantitatively detect other active ingredients, and it has certain limitations and cannot fully reflect the quality level of traditional Chinese medicine products.
  • Fingerprint technology is a newly developed method for quality control of traditional Chinese medicine.
  • the usual fingerprints remain in the evaluation of fingerprint identification or overall similarity, focusing on macroscopic features, and do not reflect well on microscopic features such as specific chromatographic peak chemical information and material content.
  • Simultaneous determination of combined fingerprinting techniques with multiple indicator components is a quality control method developed in parallel. It combines spectral efficacy research methods and separation techniques to identify the main active components (or major active ingredient groups) of traditional Chinese medicines, and to determine the index components for key monitoring of fingerprints.
  • Simultaneous determination of multiple fingerprints combined with fingerprint technology not only focuses on macroscopic features, but also monitors the content of multiple active ingredients. It can achieve microscopic and macroscopic organic combination, conforming to the overall, macroscopic and complex characteristics of traditional Chinese medicine, and can evaluate and control traditional Chinese medicine as a whole.
  • the quality of the preparation is one of the key technologies for the modernization of traditional Chinese medicine.
  • the technical problem to be solved by the present invention is to overcome the defects of the quality detection method of the existing four-mill soup preparation, and to comprehensively reflect the defects of the quality of the Si Mo Tang preparation, and to provide a multi-index component of the Si Mo Tang preparation. Simultaneous determination method, and construction method of fingerprint of Si Mo Tang preparation.
  • the invention determines the main index components of the fingerprint to be monitored by the spectral effect method and the separation and purification technology, namely, deisopoldine, isophylloside, naringin, hesperidin, neohesperidin and sorbus Potassium acid.
  • the method for simultaneously determining the multi-index component of the Si Mo Tang preparation of the present invention comprises the following steps: the test solution of the Si Mo Tang preparation is subjected to high performance liquid chromatography, and the chromatographic conditions of the high performance liquid chromatography are performed;
  • the column is an 18-inch silicon germanium bonded silica column, the mobile phase A is acetonitrile, and the mobile phase B is 0.1% by volume aqueous formic acid.
  • the elution gradient is shown in Table 1.
  • the detection wavelength is
  • the traditional Chinese medicine prescription of the Si Mo Tang is an existing Chinese medicine prescription, which comprises four kinds of herbs of woody, oyster shell, black peony and betel nut, and the ratio of parts by weight of each medicinal material is generally 100: 50-150: 50- 150: 50 ⁇ 150.
  • the preparation of the four-mill soup can be the preparation of the existing four-mill soup according to various dosage forms prepared by the traditional Chinese medicine of Si Mo Tang, such as oral liquid (such as Si Mo Tang oral liquid disclosed in Chinese Patent No. CN1106288), dropping pills, emulsification. Agents, capsules (including soft capsules), tablets or granules, and the like.
  • the above-mentioned four-mill soup preparation can be as follows The method comprises the following steps: preparing the volatile component extracted by the steam distillation method from the original medicinal material and the aqueous extract obtained by extracting the slag by water extraction and alcohol precipitation, and preparing each dosage form according to the existing method.
  • the test solution of the above-mentioned Si Mo Tang preparation can be prepared by a conventional pretreatment method of a chromatographic test solution. Specifically, for the Si Mo Tang Oral Liquid, it can be directly filtered through a microporous membrane, and the filtrate can be diluted without dilution or diluted to 100 times the original volume (the dilution solvent can be water or a mobile phase A and B with a volume ratio of 1:1).
  • the mixed solution that is, the test solution.
  • the pore diameter of the microporous membrane can be selected according to conventional conditions, and is generally 0.22 to 0.8 ⁇ m, preferably 0.45 ⁇ m.
  • microporous membranes are suitable for use in the present invention, such as polyethersulfone microporous membranes.
  • the solution in which the Si Mo Tang preparation is dissolved may be sonicated, cooled, and then filtered through a microporous membrane (same as described above), and the filtrate is supplied. Sample solution.
  • the solvent in the solution in which the Si Mo Tang preparation is dissolved may be methanol, ethanol, 40% by volume or more of methanol aqueous solution, 40% by volume of aqueous ethanol solution, chloroform, ethyl acetate, diethyl ether, petroleum Ether, acetone or cyclohexane, the first four are preferred.
  • the amount of the solvent used is such that the concentration of the Si Mo Tang preparation is suitable for chromatographic detection. Specifically, according to the concentration of the above-mentioned four-milling oral liquid for the test solution, the same concentration can be calculated according to the dosage of the other four-milling preparations.
  • the ultrasonic treatment conditions are preferably 160 to 250 W, a frequency of 40 kHz, and an ultrasonic wave of 20 to 60 minutes.
  • the injection amount of the high-performance liquid chromatography detection is selected according to the conventional knowledge in the field of chromatographic detection, and is generally 2 to 50 ⁇ M, preferably 5 to 2 ( ⁇ L is preferred.
  • the column can be an existing 18-inch silicon germanium bonded silica column of various types and specifications, such as 4.6mmX 250mm, 4.6mm X 150mm, etc. 4.6mmX 250mm.
  • the present invention is particularly preferably a Venusil XBP-C 18 column (4.6 mm X 250 mm) or an Agilent ZORBAX SB-C 18 column (4.6 mm X 250 mm), most preferably the former.
  • the elution gradient is as shown in Table 1.
  • Table 1 In order to obtain the best separation effect, when different octadecyl silicon germanium bonded silica gel columns are used, the optimum selection can be made within the range shown in Table 1.
  • the elution gradient as shown in Table 2 is most preferred. Table 2
  • the column temperature has little effect on the separation effect, and a temperature range which can be used by a conventional column can be used, and is generally 15 to 50 ° C, preferably 20 to 40 ° C.
  • the flow rate has little effect on the separation effect, and can be selected according to a conventional method in the art, and is generally 0.5 to 1.5 mL / min, preferably 0.8 to 1.2 mL / min.
  • the number of theoretical plates of the high performance liquid chromatography of the present invention is not less than 3,000 based on naringin.
  • the invention further relates to a method for constructing a fingerprint of a Si Mo Tang preparation, which comprises the following steps: using the above method to detect the Si Mo Tang preparation, and then using the traditional Chinese medicine chromatographic fingerprint similarity evaluation system software (National Pharmacopoeia Commission 2004A 1.0 version) Simulate the fingerprint of the four mill soup preparations.
  • a method for constructing a fingerprint of a Si Mo Tang preparation which comprises the following steps: using the above method to detect the Si Mo Tang preparation, and then using the traditional Chinese medicine chromatographic fingerprint similarity evaluation system software (National Pharmacopoeia Commission 2004A 1.0 version) Simulate the fingerprint of the four mill soup preparations.
  • the number of samples of the tested Si Mo Tang preparation is more than the number of samples required to establish the minimum fingerprint, generally 10 to 30, and the invention is illustrated by taking 26 batches of samples as an example.
  • the traditional Chinese medicine chromatographic fingerprint similarity evaluation system software simulation generates the fingerprint of the Si Mo Tang preparation as usual.
  • the reagents and starting materials used in the present invention are commercially available.
  • the positive effect of the invention is:
  • the invention provides a method for simultaneously determining the multi-index component of the Si Mo Tang preparation and the method for constructing the fingerprint of the Si Mo Tang preparation on the basis of clarifying the main active ingredients of the Si Mo Tang.
  • the measuring method of the invention has strong specificity, simple operation, excellent stability, precision, reproducibility and sample recovery rate, and can comprehensively detect various main active ingredients in the Si Mo Tang preparation, thereby constructing science Reasonable four-milled soup fingerprint, complete and accurate evaluation of four mills The effectiveness, safety, stability and quality uniformity of the soup preparation.
  • Fig. 1 is a chromatogram obtained by using four different chromatographic columns to determine the solution of the tetrarishamine oral solution for the test solution.
  • 1A is employed Venusil XBP-C 18 column (4.6mmX250mm), using FIG. IB is a Agilent ZORBAX SB-C 18 column (4.6mm X 250mm).
  • FIG. 2 is a chromatogram of a sample solution and a standard of the Si Mo Tang Oral Liquid in Example 3.
  • Figure 2A shows the sample solution of the Si Mo Tang Oral Liquid
  • Figure 2B shows the standard.
  • 2 is norbibeldine
  • 3 is new North American erioside
  • 4 is isophylloside
  • 5 is naringin
  • 6 is hesperidin
  • 8 is neohesperidin
  • 10 is potassium sorbate .
  • Figure 3 is a chromatogram of HPLC analysis of different concentrations of acetonitrile -0.1% aqueous formic acid (the mobile phase conditions of the present invention) in Example 5-1, wherein A, B, C and D are Table 3-1, respectively.
  • Figure 4 is a chromatogram of HPLC analysis of different gradients of acetonitrile-ammonium acetate buffer (compared to mobile phase conditions) in Example 5-2, wherein A, B, C and D are Tables 4-1 and 4-, respectively. 2,
  • Figure 5 is a quantitative limit detection chromatogram of the third standard (norgosole, metapoverin, naringin, hesperidin, neohesperidin and potassium sorbate) in Example 8.
  • Fig. 5A 4 is isoquertoside
  • 5 is naringin
  • 6 is hesperidin
  • 8 is neohesperidin
  • 10 is potassium sorbate
  • Fig. 5B 2 is norbibeldine.
  • Figure 6 is a chromatogram of the finished product of 26 batches of Si Mo Tang Oral Liquid in Example 9 (Fig. 6A), and a fingerprint of Si Mo Tang Oral Liquid (Fig. 6B). detailed description
  • the blood components flavonoids, lactones, alkaloids
  • the monomer components with higher content of blood components were identified. Separation and purification are carried out, and the index component of the fingerprint map to be monitored is determined by the carbon enthalpy propulsion rate index.
  • Monomer component activity test Each monomer component was mixed with physiological saline (pH-assisted solution if necessary), and administered to a solution of 0.30 ml/10 g body weight in a volume of 10 ml.
  • the dosage is shown in Table 3. , respectively, to determine the carbon sputum propulsion rate of each group (Liu Lingan, Cai Ying, Yan Xiaoyuan, et al, the effect of Si Mo Tang on gastrointestinal motility in mice with different functional status] [J].
  • TCM Herald, 2009, 15(12): 64-66 Table 3
  • arecoline is the main monomer in the four-mill soup to promote small bowel movements. Peel, naringin, hesperidin, neohesperidin and norbiphordine also play a role.
  • potassium sorbate is a preservative for Si Mo Tang Oral Liquid. Compared with other preservatives, it has better antibacterial and antiseptic effects and lower toxicity. Although potassium sorbate is not an active ingredient of Si Mo Tang preparation, its content can be controlled to meet the needs of the quality stability of the preparation during the effective period, and to comprehensively control the quality of the Si Mo Tang preparation. Therefore, potassium sorbate as a characteristic indicator component is of great significance for the quality control of Si Mo Tang preparation.
  • Test solution of Si Mo Tang preparation Si Mo Tang Oral Liquid (Hunan Hansen Pharmaceutical Co., Ltd., batch number 090436) 5 pieces, mixed evenly, using microporous membrane (0.45 ⁇ , polyethersulfone, SCAA-101 water) The phase needle filter) is filtered, which is the test solution.
  • High performance liquid chromatography detection Precision extraction of 5 L of the test solution, injection into high performance liquid chromatography for determination.
  • Chromatographic conditions column was Venusil XBP-C 18 column (4.6mm X 250mm), a column temperature of 30 ° C, a flow rate of lml min- 1, acetonitrile mobile phase A, mobile phase B 0.1% by volume aqueous formic acid
  • the elution gradient is shown in Table 2.
  • the detection wavelength is 190 ⁇ 400 nm, and the peaks in 45 min and their retention time and peak area are recorded.
  • On-line detection of the test solution in the ultraviolet region of 190 ⁇ 400 nm by using a diode array detector revealed that the obtained peaks were mainly flavonoids in the clam shell and the raw materials in the black peony. Alkaloids. In the black medicinal herb, the maximum absorption is at 280 nm. The ultraviolet absorption behavior of flavonoids in the oyster shell is very similar. The absorption is the strongest at 283 nm, and the information provided is the most abundant. The ratio is suitable, so a comprehensive selection of 283 nm is used as the detection wavelength.
  • the test solution of the Si Mo Tang preparation was the same as in Example 1.
  • High performance liquid chromatography detection The column was a Venusil XBP-C 18 column (4.6 mm X 250 mm) or an Agilent ZORBAX SB-C 18 column (4.6 mm X 250 mm) with a detection wavelength of 283 nm, and other conditions were the same as in Example 1.
  • the test solution of the Si Mo Tang preparation was the same as in Example 1.
  • High-performance liquid chromatography detection method respectively, accurately extract the standard product and the test solution 5 ⁇ 1, respectively, and inject them into high performance liquid chromatography for measurement.
  • the column was a Venusil XBP-C 18 column (4.6 mm X 250 mm) with a detection wavelength of 283 nm, and other conditions were the same as in Example 1. 2, the experimental results
  • chromatograms of the test solution and the standard of the Si Mo Tang Oral Liquid are shown in Fig. 2A and Fig. 2B, respectively.
  • 2 is norbibelol (retention time: 13.1min)
  • 3 is new North American ergoside (retention time: 19.9 min)
  • 4 is isoquerment (retention time: 21.7 min)
  • 5 is pomelo Decoction (retention time: 22.6 min)
  • 6 is hesperidin (retention time: 23.2 min)
  • 8 is neohesperidin (retention time: 24.0 min)
  • 10 is potassium sorbate (retention time: 25.1 min).
  • the test solution of the Si Mo Tang preparation was the same as in Example 1.
  • High performance liquid chromatography detection method The detection time was 70 min, and other conditions were the same as in Example 3.
  • the column is a Venusil XBP-C 18 column (4.6mmX 250mm) column, the mobile phase A is acetonitrile, and the mobile phase B is 0.1% by volume aqueous formic acid.
  • the elution gradient is shown in Table 3-1, 3-2, 3-3.
  • the column temperature is 30 ° C
  • the flow rate is 1.0 ml min -1
  • the detection wavelength is 283 nm
  • the chromatogram is shown in Figures 3A, B, C and D.
  • the column was a Venusil XBP-C 18 column (4.6 mm X 250 mm) with a column temperature of 30 ° C, a flow rate of 1 mL-min" 1 , and a detection wavelength of 283 nm.
  • the above-mentioned acetonitrile-ammonium acetate buffer was used as the mobile phase, and the retention time of the chromatographic peak changed greatly.
  • potassium sorbate as an example, when the gradient elution conditions change, the retention time of the chromatographic peak changes greatly, and it may partially overlap with the chromatographic peaks of naringin, hesperidin or neohesperidin in the clam shell or Completely overlapping. Therefore, the method established using this mobile phase lacks certain durability. Moreover, the instrument and column maintenance requirements are higher after elution with buffer salts.
  • the column was a Venusil XBP-C 18 column (4.6 mm X 250 mm) column, mobile phase A was acetonitrile, and mobile phase B was a 0.1% by volume aqueous solution of formic acid.
  • HPLC analysis was carried out according to the elution gradient of Example 1. Flow rate and column temperature, as well as retention time, symmetry factor, resolution and theoretical plate number As shown in Table 5;
  • the standard samples (norgosine, isophylloside, naringin, hesperidin, neohesperidin and potassium sorbate) are shown in Table 8.
  • the signal-to-noise ratio S/N 10 or 3, which are the limit of quantitation and detection limit of each of the above indicators.
  • the quantitative limit chromatograms of the various indicator components are shown in Figures 5A and 5B.
  • the concentrations of norbipotrel were 43.24 g/mL, 86.48 g/mL, and 172.96 g/mL, respectively.
  • the concentrations of isoquertoside were 40.24 g/mL and 80.48, respectively.
  • g/mL, 402.4 ⁇ ⁇ / ⁇ the concentration of naringin was 101.64 g/mL, 203.3 (Vg/mL, 1016.4 g/mL, the concentration of hesperidin was 24.12 g/mL, 48.24 g/mL, respectively.
  • the concentrations of neohesperidin were 96.44 g/mL, 192.88 g/mL, and 964.4 g/mL, respectively.
  • the potassium sorbate concentrations were 50.472 g/mL, 252.36 g/mL, and 504.72 g/mL, respectively.
  • the sample volume was 5 L, and the concentration of each group was repeated 6 times.
  • Addition recovery rate % (measured amount - the amount of the indicator component contained in the test solution) / actual addition amount ⁇ ⁇ % Table 13-1 Sample test results of deisomethodazole
  • the detection method of the present invention has a good sample recovery rate for each index component.
  • the sample was prepared in 26 batches of Si Mo Tang Oral Liquid, and the test solution was prepared according to the method of Example 3, and subjected to HPLC detection.
  • the chromatogram is shown in Fig. 6A.
  • Fig. 6B is a fingerprint of the four-milling oral liquid.
  • characteristic fingerprint peaks According to the determination results of 26 batches of Si Mo Tang oral liquid, with the naringin standard as the reference peak, 9 characteristic fingerprint peaks were identified from 20 characteristic fingerprint peaks, namely, the de-isolated wave Erding (No. 3), New North American Glycyrrhizin (No. 6), Isoflavone (No. 7), Naringin (No. 8), Hesperidin (No. 9), Neohesperidin (No. 11) Potassium sorbate (No. 13), Chuan Chenshen (No. 18) and Red Tangerine (No. 19).
  • the preparation of the four-mill soup preparations meeting the following standards is a preparation that meets the quality standards:
  • the chromatographic peaks in the figure should be consistent with the characteristic peaks of the fingerprint of Si Mo Tang Oral Liquid, and the similarity is not less than 0.90.
  • Table 15 Relative retention schedule of each characteristic peak in the multi-index fingerprint of Si Mo Tang (minutes)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Library & Information Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)

Abstract

Provided are methods for simultaneously determinating multi-component of Simotang and fingerprint building method thereof. The Simotang is prepared from vladimiria root, bitter orange, spicebush root and areca seed. In the method the Simotang sample solution is detected by HPLC, with a column of octadecyl silane bonded silica gel column, acetonitrile as the mobile phase A, 0.1%(by volume)formic acid aqueous solution as the mobile phase B, using gradient elution, and with the detection wavelength of 283nm. The fingerprint of the Simotang is built by the said determination method, and then by computer simulation. The determination method is simple with high specificity, excellent stability, precision, reproducibility and average recovery, and can detect a variety of active ingredients of the Simotang, thereby, scientific and rational fingerprint can be obtained, and effectiveness, security, stability and homogeneity of the Simotang can be completed and accurately evaluated.

Description

四磨汤制剂的多指标成分同时测定及其指紋图谱构建方法  Simultaneous determination of multi-index components of Si Mo Tang preparation and its fingerprint mapping method
技术领域 Technical field
本发明涉及一种四磨汤制剂的多指标成分同时测定方法, 以及四磨汤制 剂指紋图谱的构建方法。 背景技术  The invention relates to a method for simultaneously determining a multi-index component of a Si Mo Tang preparation, and a method for constructing a fingerprint of a Si Mo Tang preparation. Background technique
四磨汤中药方包括木香、 枳壳、 乌药和槟榔四味药材。 该方具有顺气降 逆, 消积止痛功效, 可用于婴幼儿乳食内滞证(证见腹胀、腹痛、 啼哭不安、 厌食纳差、 腹泻或便秘), 中老年气滞、 食积症 (证见脘腹胀满、 腹痛、 便 秘), 以及腹部手术后促进肠胃功能的恢复。 此外, 还有文献报道其用于治 疗新生儿黄疸、 胃食管返流、 病毒性肠炎、 便秘型肠易激综合征和中毒性肠 麻痹等疾病的成功病例。  The four-bred Chinese medicine includes four kinds of herbs: woody, oyster shell, black peony and betel nut. The side has the effect of reducing qi and reducing the pain, eliminating the pain and eliminating pain. It can be used for infants and young children with milk stagnation syndrome (see bloating, abdominal pain, crying, anorexia, diarrhea or constipation), middle-aged qi stagnation, food dysfunction (certificate) See abdominal fullness, abdominal pain, constipation), and the recovery of gastrointestinal function after abdominal surgery. In addition, there are reports of successful cases for the treatment of neonatal jaundice, gastroesophageal reflux, viral enteritis, constipation-type irritable bowel syndrome and toxic intestinal paralysis.
现有技术中, 根据四磨汤中药方, 已制得多种剂型的四磨汤制剂。 通常 的制备工艺一般为: 将四味原药材采用水蒸气蒸馏法提取芳香水, 芳香水富 集挥发油后直接备用或包合后备用, 再将药渣用水提醇沉得水提液, 水提液 可浓缩干燥得干膏粉, 将上述芳香水或挥发油, 以及水提液或干膏粉, 选择 合适的辅料, 即制备成口服液、 滴丸、 乳化剂、 胶囊、 软胶囊、 片剂、 颗粒 剂等多种剂型。  In the prior art, according to the traditional Chinese medicine prescription of Si Mo Tang, various preparations of the Si Mo Tang preparation have been prepared. The usual preparation process is generally as follows: The four kinds of original medicinal materials are extracted by steam distillation to extract the aromatic water, and the aromatic water is enriched in the volatile oil, and then directly used or packaged for later use, and then the slag is extracted with water to obtain an aqueous extract, and the water is extracted. The liquid can be concentrated and dried to obtain a dry paste powder, and the above-mentioned aromatic water or volatile oil, as well as an aqueous extract or a dry paste powder, and an appropriate auxiliary material is selected, thereby preparing an oral liquid, a dropping pill, an emulsifier, a capsule, a soft capsule, a tablet, A variety of dosage forms such as granules.
例如, 中国专利 94110842.2 (公开号 CN1106288 )公开了一种四磨汤口 服液。其采用中药槟榔 10〜25%、木香 10〜25%、枳壳 20〜30%、乌药 20〜30%, 取上述药材饮片提取芳香性成分, 另存; 将药渣加水煎煮, 合并滤液, 浓缩, 加乙醇静置, 滤取清液, 减压回收乙醇, 加水煮沸, 过滤去渣, 滤液中加入 芳香性成分水液及适量辅料、 滤过、 分装、 灭菌即得。  For example, Chinese Patent No. 94110842.2 (Publication No. CN1106288) discloses a four-mill soup mouth liquid. It adopts Chinese traditional medicine betel nut 10~25%, woody incense 10~25%, oyster shell 20~30%, black peony 20~30%, take the above-mentioned medicinal herbs to extract aromatic components, and save; the slag is added with water to cook, and the filtrate is combined. , Concentrate, add ethanol to stand, filter the clear liquid, recover the ethanol under reduced pressure, add water to boil, filter to remove the residue, add the aromatic component water and appropriate amount of auxiliary materials to the filtrate, filter, dispense and sterilize.
四磨汤包括槟榔、木香、枳壳和乌药, 所含成分复杂多样。据文献报道, 木香主要成分包括萜类、生物碱、 体和氨基酸,枳壳主要成分包括黄酮苷、 烯烃和生物碱,乌药主要成分包括萜类和生物碱,槟榔主要成分包括生物碱、 鞣质和氨基酸。 The four-mill soup includes betel nut, woody, clam shell and black peony. The ingredients are complex and diverse. According to reports in the literature, the main components of woody agaric include acarids, alkaloids, body and amino acids, and the main components of the clam shell include flavonoid glycosides. Olefin and alkaloids, the main components of black peony include steroids and alkaloids, and the main components of betel nut include alkaloids, tannins and amino acids.
但四磨汤口服液现有的质量标准为部颁标准 WS- 10040 ( ZD-0040 ) -2002 该标准 "鉴别"项采用 TLC法对木香和槟榔进行鉴别: 取四磨汤口服液成 品, 用有机溶剂进行提取, 经前处理后制备成供试品溶液; 对照药材用适宜 有机溶剂提取, 经前处理后制备成对照药材溶液; 供试品溶液和对照药材溶 液点板于硅胶 G薄层板,采用适宜展开剂展开,显色剂显色,进行药材鉴别。 "含量测定"项采用高效液相色谱法测定指标性成分柚皮苷含量: 用十八垸 基硅垸键合硅胶为填充剂; 甲醇 -1%醋酸 (38: 62) 为流动相; 检测波长为 283nm。 四磨汤口服液成品经 D1Q1型大孔吸附树脂柱洗脱, 收集洗脱液, 制 备成供试品溶液; 取柚皮苷对照品制备成对照品溶液; 采用外标法计算柚皮 苷含量。 该标准未对其他有效成分进行定量检测, 存在一定局限性, 不能全 面反映中药产品的质量水平。 However, the existing quality standard of Si Mo Tang Oral Liquid is the Ministry of Standards WS-10040 (ZD-0040) -2002. The standard "identification" item uses TLC method to identify woody and betel nut: Take the finished product of Si Mo Tang Oral Liquid, The organic solvent is used for extraction, and is prepared into a test solution after pretreatment; the reference drug is extracted with a suitable organic solvent, and is prepared into a reference drug solution after pretreatment; the test solution and the reference drug solution are plated on a thin layer of silica gel G. The plate is developed with a suitable developing agent, and the coloring agent is developed to identify the medicine. "Content determination" item was determined by high performance liquid chromatography with the content of naringin as an indicator: octadecyl silicon germanium bonded silica as a filler; methanol-1% acetic acid (38: 62) as mobile phase; detection wavelength It is 283 nm. The finished product of Si Mo Tang Oral Liquid is eluted by D 1Q1 macroporous adsorption resin column, and the eluent is collected to prepare a test solution; the reference substance of naringin is prepared as a reference solution; the naringin is calculated by external standard method content. This standard does not quantitatively detect other active ingredients, and it has certain limitations and cannot fully reflect the quality level of traditional Chinese medicine products.
指紋图谱技术是新发展的中药质量控制方法。但通常的指紋图谱停留在 指紋性鉴别或整体相似度的评价, 注重宏观特征, 对于微观特征如具体色谱 峰化学信息和物质含量没有较好体现。多指标成分同时测定联合指紋图谱技 术是进一歩发展的质量控制方法, 其结合谱效学研究手段和分离技术明确中 药主要有效成分(或主要有效成分群), 确定指紋图谱重点监控的指标成分。 多指标同时测定联合指紋图谱技术既注重宏观特征, 又监控多个有效成分的 含量, 可实现微观和宏观的有机结合, 符合中医药整体、宏观、复杂的特点, 可从整体上评价和控制中药制剂的质量, 是中药现代化关键技术之一。  Fingerprint technology is a newly developed method for quality control of traditional Chinese medicine. However, the usual fingerprints remain in the evaluation of fingerprint identification or overall similarity, focusing on macroscopic features, and do not reflect well on microscopic features such as specific chromatographic peak chemical information and material content. Simultaneous determination of combined fingerprinting techniques with multiple indicator components is a quality control method developed in parallel. It combines spectral efficacy research methods and separation techniques to identify the main active components (or major active ingredient groups) of traditional Chinese medicines, and to determine the index components for key monitoring of fingerprints. Simultaneous determination of multiple fingerprints combined with fingerprint technology not only focuses on macroscopic features, but also monitors the content of multiple active ingredients. It can achieve microscopic and macroscopic organic combination, conforming to the overall, macroscopic and complex characteristics of traditional Chinese medicine, and can evaluate and control traditional Chinese medicine as a whole. The quality of the preparation is one of the key technologies for the modernization of traditional Chinese medicine.
对于四磨汤制剂, 亟需建立检测方法, 构建多指标成分同时测定联合指 紋图谱技术, 以更全面准确的监控四磨汤制剂的质量。  For the Si Mo Tang preparation, it is urgent to establish a detection method, construct a multi-indicator component and simultaneously measure the joint fingerprint pattern technique to more comprehensively and accurately monitor the quality of the Si Mo Tang preparation.
发明内容 本发明所要解决的技术问题是为了克服现有的四磨汤制剂的质量检测 方法所检测的有效成分单一, 不能全面反应四磨汤制剂质量的缺陷, 而提供 一种四磨汤制剂多指标成分同时测定方法, 以及四磨汤制剂指紋图谱的构建 方法。 Summary of the invention The technical problem to be solved by the present invention is to overcome the defects of the quality detection method of the existing four-mill soup preparation, and to comprehensively reflect the defects of the quality of the Si Mo Tang preparation, and to provide a multi-index component of the Si Mo Tang preparation. Simultaneous determination method, and construction method of fingerprint of Si Mo Tang preparation.
本发明通过谱效学方法以及分离纯化技术,确定了指紋图谱需监控的主 要指标成分, 即去甲异波尔定、 异柚皮苷、 柚皮苷、 橙皮苷、 新橙皮苷和山 梨酸钾。 进一歩经实验摸索, 最终建立了一种专属性强、 操作简便, 且稳定 性、 精密度、 重现性和加样回收率均良好的检测方法, 从而首次建立了科学 合理的四磨汤制剂的多指标成分指紋图谱。  The invention determines the main index components of the fingerprint to be monitored by the spectral effect method and the separation and purification technology, namely, deisopoldine, isophylloside, naringin, hesperidin, neohesperidin and sorbus Potassium acid. After a glimpse of the experiment, a test method with strong specificity, simple operation, and good stability, precision, reproducibility and sample recovery rate was established, thus establishing a scientific and rational four-mill soup preparation for the first time. Multiple indicator component fingerprints.
本发明的四磨汤制剂多指标成分同时测定方法包括如下歩骤:将四磨汤 制剂的供试品溶液进行高效液相色谱法检测, 即可; 所述的高效液相色谱法 的色谱条件为: 色谱柱为十八垸基硅垸键合硅胶柱, 流动相 A为乙腈, 流动 相 B为体积百分比 0.1%的甲酸水溶液, 洗脱梯度如表 1所示, 检测波长为  The method for simultaneously determining the multi-index component of the Si Mo Tang preparation of the present invention comprises the following steps: the test solution of the Si Mo Tang preparation is subjected to high performance liquid chromatography, and the chromatographic conditions of the high performance liquid chromatography are performed; The column is an 18-inch silicon germanium bonded silica column, the mobile phase A is acetonitrile, and the mobile phase B is 0.1% by volume aqueous formic acid. The elution gradient is shown in Table 1. The detection wavelength is
Figure imgf000004_0001
Figure imgf000004_0001
本发明中, 所述的四磨汤中药方为现有中药方, 其包括木香、 枳壳、 乌 药和槟榔四味药材,各药材重量份数比一般为 100: 50-150: 50-150: 50〜150。 所述的四磨汤制剂可为现有的根据四磨汤中药方制备的各种剂型的四磨汤 制剂, 例如口服液 (如中国专利 CN1106288公开的四磨汤口服液)、 滴丸、 乳化剂、 胶囊 (包括软胶囊)、 片剂或颗粒剂等。 上述四磨汤制剂可由下述 方法制得: 将原药材经水蒸气蒸馏法提取的挥发性成分, 与药渣经水提醇沉 提取的水提物, 按现有方法制成各剂型。 In the present invention, the traditional Chinese medicine prescription of the Si Mo Tang is an existing Chinese medicine prescription, which comprises four kinds of herbs of woody, oyster shell, black peony and betel nut, and the ratio of parts by weight of each medicinal material is generally 100: 50-150: 50- 150: 50~150. The preparation of the four-mill soup can be the preparation of the existing four-mill soup according to various dosage forms prepared by the traditional Chinese medicine of Si Mo Tang, such as oral liquid (such as Si Mo Tang oral liquid disclosed in Chinese Patent No. CN1106288), dropping pills, emulsification. Agents, capsules (including soft capsules), tablets or granules, and the like. The above-mentioned four-mill soup preparation can be as follows The method comprises the following steps: preparing the volatile component extracted by the steam distillation method from the original medicinal material and the aqueous extract obtained by extracting the slag by water extraction and alcohol precipitation, and preparing each dosage form according to the existing method.
本发明中,所述的四磨汤制剂的供试品溶液可按常规的色谱供试溶液的 预处理方法制备而得。具体的,对于四磨汤口服液,可直接用微孔滤膜过滤, 滤液可不经稀释, 或者稀释至原体积 100倍以下(稀释溶剂可为水或体积比 1 : 1的流动相 A和 B的混合溶液), 即为供试品溶液。 所述的微孔滤膜的孔 径可按常规条件选择, 一般为 0.22〜0.8μηι, 优选 0.45μηι。 各种类的微孔滤 膜均适用本发明, 如聚醚砜微孔滤膜。 对于其他剂型(如其他液体制剂或固 体制剂) 的四磨汤制剂, 可将溶有四磨汤制剂的溶液经超声处理, 冷却, 之 后用微孔滤膜(同前述) 过滤, 滤液即为供试品溶液。 其中, 所述的溶有四 磨汤制剂的溶液中的溶剂可为甲醇、 乙醇、体积百分比 40%以上的甲醇水溶 液、 体积百分比 40〜95%的乙醇水溶液、 氯仿、 乙酸乙酯、 乙醚、 石油醚、 丙酮或环己垸, 优选前四种。所述的溶剂的用量以使四磨汤制剂的浓度适宜 色谱检测为准。 具体的, 可根据上述四磨汤口服液供试品溶液中的浓度, 按 其他四磨汤制剂的药材用量折算配制成相同浓度。所述的超声处理的条件较 佳的为 160〜250W, 频率 40kHz, 超声 20〜60min。  In the present invention, the test solution of the above-mentioned Si Mo Tang preparation can be prepared by a conventional pretreatment method of a chromatographic test solution. Specifically, for the Si Mo Tang Oral Liquid, it can be directly filtered through a microporous membrane, and the filtrate can be diluted without dilution or diluted to 100 times the original volume (the dilution solvent can be water or a mobile phase A and B with a volume ratio of 1:1). The mixed solution), that is, the test solution. The pore diameter of the microporous membrane can be selected according to conventional conditions, and is generally 0.22 to 0.8 μm, preferably 0.45 μm. Various types of microporous membranes are suitable for use in the present invention, such as polyethersulfone microporous membranes. For the four-mill soup preparations of other dosage forms (such as other liquid preparations or solid preparations), the solution in which the Si Mo Tang preparation is dissolved may be sonicated, cooled, and then filtered through a microporous membrane (same as described above), and the filtrate is supplied. Sample solution. Wherein, the solvent in the solution in which the Si Mo Tang preparation is dissolved may be methanol, ethanol, 40% by volume or more of methanol aqueous solution, 40% by volume of aqueous ethanol solution, chloroform, ethyl acetate, diethyl ether, petroleum Ether, acetone or cyclohexane, the first four are preferred. The amount of the solvent used is such that the concentration of the Si Mo Tang preparation is suitable for chromatographic detection. Specifically, according to the concentration of the above-mentioned four-milling oral liquid for the test solution, the same concentration can be calculated according to the dosage of the other four-milling preparations. The ultrasonic treatment conditions are preferably 160 to 250 W, a frequency of 40 kHz, and an ultrasonic wave of 20 to 60 minutes.
本发明中,所述的高效液相色谱法检测的进样量根据色谱检测领域常规 知识选择, 一般为 2〜50μΙ^, 以 5〜2(^L为佳。  In the present invention, the injection amount of the high-performance liquid chromatography detection is selected according to the conventional knowledge in the field of chromatographic detection, and is generally 2 to 50 μM, preferably 5 to 2 (^L is preferred.
本发明中,所述的色谱柱可为现有的各种型号和规格的十八垸基硅垸键 合硅胶柱, 如 4.6mmX 250mm、 4.6mm X 150mm等径长规格均可适用, 最优 选 4.6mmX 250mm。 本发明特别优选 Venusil XBP-C18柱 (4.6mmX 250mm) 或 Agilent ZORBAX SB-C18柱 (4.6mm X 250mm), 最优选前者。 In the present invention, the column can be an existing 18-inch silicon germanium bonded silica column of various types and specifications, such as 4.6mmX 250mm, 4.6mm X 150mm, etc. 4.6mmX 250mm. The present invention is particularly preferably a Venusil XBP-C 18 column (4.6 mm X 250 mm) or an Agilent ZORBAX SB-C 18 column (4.6 mm X 250 mm), most preferably the former.
本发明中, 所述的洗脱梯度如表 1所示。 为获得最优分离效果, 采用不 同的十八垸基硅垸键合硅胶柱时, 可在如表 1所示的范围内进行最优选择。 当采用本发明特别优选的 Venusil XBP-C18柱 (4.6mmX 250mm) 或 Agilent ZORBAX SB-C18柱 (4.6mmX 250mm) 时, 最优选如表 2所示的洗脱梯度。 表 2 In the present invention, the elution gradient is as shown in Table 1. In order to obtain the best separation effect, when different octadecyl silicon germanium bonded silica gel columns are used, the optimum selection can be made within the range shown in Table 1. When a particularly preferred Venusil XBP-C 18 column (4.6 mm X 250 mm) or an Agilent ZORBAX SB-C 18 column (4.6 mm X 250 mm) of the present invention is used, the elution gradient as shown in Table 2 is most preferred. Table 2
Figure imgf000006_0001
Figure imgf000006_0001
本发明中, 柱温对分离效果影响不大, 可采用常规的色谱柱可以允许使 用的温度范围, 一般为 15〜50°C, 较佳的为 20〜40°C。  In the present invention, the column temperature has little effect on the separation effect, and a temperature range which can be used by a conventional column can be used, and is generally 15 to 50 ° C, preferably 20 to 40 ° C.
本发明中, 流速对分离效果影响不大, 可按本领域常规方法选择, 一般 为 0.5〜1.5 mL / min, 较佳的为 0.8〜1.2 mL / min。  In the present invention, the flow rate has little effect on the separation effect, and can be selected according to a conventional method in the art, and is generally 0.5 to 1.5 mL / min, preferably 0.8 to 1.2 mL / min.
本发明的高效液相色谱法理论塔板数按柚皮苷计算不低于 3000。  The number of theoretical plates of the high performance liquid chromatography of the present invention is not less than 3,000 based on naringin.
本发明进一歩涉及一种四磨汤制剂指紋图谱的构建方法, 其包括如下歩 骤: 采用前述方法检测四磨汤制剂, 再采用中药色谱指紋图谱相似度评价系 统软件 (国家药典委 2004A 1.0版) 模拟生成四磨汤制剂指紋图谱。  The invention further relates to a method for constructing a fingerprint of a Si Mo Tang preparation, which comprises the following steps: using the above method to detect the Si Mo Tang preparation, and then using the traditional Chinese medicine chromatographic fingerprint similarity evaluation system software (National Pharmacopoeia Commission 2004A 1.0 version) Simulate the fingerprint of the four mill soup preparations.
其中,所检测的四磨汤制剂的样品份数为建立指紋图谱的最低所需要的 样品份数以上, 一般以 10〜30为宜, 本发明以 26批样品为例进行说明。  Wherein, the number of samples of the tested Si Mo Tang preparation is more than the number of samples required to establish the minimum fingerprint, generally 10 to 30, and the invention is illustrated by taking 26 batches of samples as an example.
其中,所述的采用中药色谱指紋图谱相似度评价系统软件模拟生成四磨 汤制剂指紋图谱按常规进行操作。  Among them, the traditional Chinese medicine chromatographic fingerprint similarity evaluation system software simulation generates the fingerprint of the Si Mo Tang preparation as usual.
在符合本领域常识的基础上, 上述各优选条件, 可任意组合, 即得本发 明各较佳实例。  The above preferred conditions can be arbitrarily combined on the basis of the common knowledge in the art, that is, the preferred examples of the present invention.
本发明所用试剂和原料均市售可得。  The reagents and starting materials used in the present invention are commercially available.
本发明的积极进歩效果在于: 本发明在明确了四磨汤主要有效成分的基 础上, 提供了一种四磨汤制剂多指标成分同时测定方法, 以及四磨汤制剂指 紋图谱构建方法。 本发明的测定方法专属性强、 操作简便、 且具有优异的稳 定性、 精密度、 重现性和加样回收率, 可较全面的检测四磨汤制剂中多种主 要有效成分, 从而构建科学合理的四磨汤指紋图谱, 完整、 准确的评价四磨 汤制剂的有效性、 安全性、 稳定性和质量均一性。 附图说明 The positive effect of the invention is: The invention provides a method for simultaneously determining the multi-index component of the Si Mo Tang preparation and the method for constructing the fingerprint of the Si Mo Tang preparation on the basis of clarifying the main active ingredients of the Si Mo Tang. The measuring method of the invention has strong specificity, simple operation, excellent stability, precision, reproducibility and sample recovery rate, and can comprehensively detect various main active ingredients in the Si Mo Tang preparation, thereby constructing science Reasonable four-milled soup fingerprint, complete and accurate evaluation of four mills The effectiveness, safety, stability and quality uniformity of the soup preparation. DRAWINGS
图 1为实施例 2采用两种不同色谱柱测定四磨汤口服液供试品溶液所得 色谱图。 图 1A为采用 Venusil XBP-C18柱(4.6mmX250mm), 图 IB为采用 Agilent ZORBAX SB-C18柱 (4.6mm X 250mm)。 Fig. 1 is a chromatogram obtained by using four different chromatographic columns to determine the solution of the tetrarishamine oral solution for the test solution. 1A is employed Venusil XBP-C 18 column (4.6mmX250mm), using FIG. IB is a Agilent ZORBAX SB-C 18 column (4.6mm X 250mm).
图 2为实施例 3中四磨汤口服液供试品溶液和标准品的色谱图。 图 2A 为四磨汤口服液供试品溶液, 图 2B为标准品。 其中, 2为去甲异波尔定, 3 为新北美圣草苷, 4为异柚皮苷, 5为柚皮苷, 6为橙皮苷, 8为新橙皮苷, 10为山梨酸钾。  2 is a chromatogram of a sample solution and a standard of the Si Mo Tang Oral Liquid in Example 3. Figure 2A shows the sample solution of the Si Mo Tang Oral Liquid, and Figure 2B shows the standard. Among them, 2 is norbibeldine, 3 is new North American erioside, 4 is isophylloside, 5 is naringin, 6 is hesperidin, 8 is neohesperidin, 10 is potassium sorbate .
图 3为实施例 5-1中采用不同梯度的乙腈 -0.1%的甲酸水溶液(本发明流 动相条件) 进行 HPLC分析的色谱图, 其中, A、 B、 C和 D分别为表 3-1、 Figure 3 is a chromatogram of HPLC analysis of different concentrations of acetonitrile -0.1% aqueous formic acid (the mobile phase conditions of the present invention) in Example 5-1, wherein A, B, C and D are Table 3-1, respectively.
3- 2、 3-3和 3-4所示的洗脱梯度进行洗脱的色谱图。 Chromatograms of the elution gradients shown in 3-2, 3-3, and 3-4.
图 4为实施例 5-2中采用不同梯度的乙腈-醋酸铵缓冲液(对比流动相条 件) 进行 HPLC分析的色谱图, 其中, A、 B、 C和 D分别为表 4-1、 4-2、 Figure 4 is a chromatogram of HPLC analysis of different gradients of acetonitrile-ammonium acetate buffer (compared to mobile phase conditions) in Example 5-2, wherein A, B, C and D are Tables 4-1 and 4-, respectively. 2,
4- 3和 4-4所示的洗脱梯度进行洗脱的色谱图; 1为山梨酸钾的色谱峰。 Chromatograms of the elution gradients shown in 4- 3 and 4-4; 1 is the chromatographic peak of potassium sorbate.
图 5为实施例 8中第 3节标准品 (去甲异波尔定、 异柚皮苷、 柚皮苷、 橙皮苷、 新橙皮苷和山梨酸钾) 的定量限检测色谱图。 图 5A中, 4为异柚 皮苷, 5为柚皮苷, 6为橙皮苷, 8为新橙皮苷, 10为山梨酸钾, 图 5B中, 2为去甲异波尔定。  Figure 5 is a quantitative limit detection chromatogram of the third standard (norgosole, metapoverin, naringin, hesperidin, neohesperidin and potassium sorbate) in Example 8. In Fig. 5A, 4 is isoquertoside, 5 is naringin, 6 is hesperidin, 8 is neohesperidin, 10 is potassium sorbate, and in Fig. 5B, 2 is norbibeldine.
图 6为实施例 9中 26批四磨汤口服液成品的色谱图 (图 6A) , 以及四 磨汤口服液指紋图谱 (图 6B)。 具体实施方式  Figure 6 is a chromatogram of the finished product of 26 batches of Si Mo Tang Oral Liquid in Example 9 (Fig. 6A), and a fingerprint of Si Mo Tang Oral Liquid (Fig. 6B). detailed description
下面通过实施例的方式进一歩说明本发明,但并不因此将本发明限制在 所述的实施例范围之中。 参考实施例 检测指标成分的确定 The invention is further illustrated by the following examples, which are not intended to limit the invention. Determination of the detection index component in the reference embodiment
运用血清药物化学、 药物代谢动力学等手段和方法, 明确了四磨汤制剂 中的入血成分 (黄酮类、 内酯类、 生物碱类), 并对含量较高入血成分的单 体成分进行分离纯化,再以碳沬推进率为指标确定指紋图谱需监控的指标成分。  Using blood medicinal chemistry, pharmacokinetics and other means and methods, the blood components (flavonoids, lactones, alkaloids) in the Si Mo Tang preparations were identified, and the monomer components with higher content of blood components were identified. Separation and purification are carried out, and the index component of the fingerprint map to be monitored is determined by the carbon enthalpy propulsion rate index.
单体成分活性试验: 将各单体成分用生理盐水(必要时调 pH值助溶)配 制药液, 按 0.30ml/10g体重灌胃, 给药体积为 10ml, 给药剂量如表 3所示, 分别测定各组碳沬推进率(刘令安, 蔡莹, 蔺晓源等, 四磨汤对不同机能状 态小鼠胃肠运动的影响 [J].中医药导报, 2009, 15(12): 64-66) , 如表 3所示: 表 3  Monomer component activity test: Each monomer component was mixed with physiological saline (pH-assisted solution if necessary), and administered to a solution of 0.30 ml/10 g body weight in a volume of 10 ml. The dosage is shown in Table 3. , respectively, to determine the carbon sputum propulsion rate of each group (Liu Lingan, Cai Ying, Yan Xiaoyuan, et al, the effect of Si Mo Tang on gastrointestinal motility in mice with different functional status] [J]. TCM Herald, 2009, 15(12): 64-66 ), as shown in Table 3: Table 3
Figure imgf000008_0001
Figure imgf000008_0001
*与空白组相比 P<0.5, **与空白组相比 P<0.1。  * P < 0.5 compared with the blank group, ** P < 0.1 compared with the blank group.
由上述数据表明,槟榔碱是四磨汤中具有促进小肠蠕动作用的主要单体 皮苷、 异柚皮苷、 橙皮苷、 新橙皮苷和去甲异波尔定也在其中发挥了一定的 作用。 According to the above data, arecoline is the main monomer in the four-mill soup to promote small bowel movements. Peel, naringin, hesperidin, neohesperidin and norbiphordine also play a role.
此外, 山梨酸钾为四磨汤口服液的防腐剂, 与其他防腐剂相比, 其抑菌 防腐效果较好, 毒性较低。 山梨酸钾虽不是四磨汤制剂的有效成分, 但对其 含量进行控制, 既可满足制剂在有效期内质量稳定性的需要, 又可全面控制 四磨汤制剂的质量。 因此, 山梨酸钾作为特征性指标成分用于四磨汤制剂的 质量控制, 具有十分重要的意义。  In addition, potassium sorbate is a preservative for Si Mo Tang Oral Liquid. Compared with other preservatives, it has better antibacterial and antiseptic effects and lower toxicity. Although potassium sorbate is not an active ingredient of Si Mo Tang preparation, its content can be controlled to meet the needs of the quality stability of the preparation during the effective period, and to comprehensively control the quality of the Si Mo Tang preparation. Therefore, potassium sorbate as a characteristic indicator component is of great significance for the quality control of Si Mo Tang preparation.
实施例 1 检测波长的确定  Example 1 Determination of Detection Wavelength
1、 材料和方法:  1. Materials and methods:
四磨汤制剂的供试品溶液:四磨汤口服液(湖南汉森制药股份有限公司, 批号 090436) 5支, 混合均匀, 用微孔滤膜 (0.45μηι, 聚醚砜, SCAA-101 水相针式滤器) 滤过, 即为供试品溶液。  Test solution of Si Mo Tang preparation: Si Mo Tang Oral Liquid (Hunan Hansen Pharmaceutical Co., Ltd., batch number 090436) 5 pieces, mixed evenly, using microporous membrane (0.45μηι, polyethersulfone, SCAA-101 water) The phase needle filter) is filtered, which is the test solution.
高效液相色谱法检测: 精密吸取供试品的溶液 5 L, 注入高效液相色谱 仪进行测定。 色谱条件: 色谱柱为 Venusil XBP-C18柱 ( 4.6mm X 250mm), 柱温为 30°C, 流速为 lml min—1 , 流动相 A为乙腈, 流动相 B为体积百分比 0.1%的甲酸水溶液, 洗脱梯度如表 2所示, 检测波长为 190〜400 nm, 记录 45min内的色谱峰及其保留时间和峰面积。 High performance liquid chromatography detection: Precision extraction of 5 L of the test solution, injection into high performance liquid chromatography for determination. Chromatographic conditions: column was Venusil XBP-C 18 column (4.6mm X 250mm), a column temperature of 30 ° C, a flow rate of lml min- 1, acetonitrile mobile phase A, mobile phase B 0.1% by volume aqueous formic acid The elution gradient is shown in Table 2. The detection wavelength is 190~400 nm, and the peaks in 45 min and their retention time and peak area are recorded.
表 2  Table 2
Figure imgf000009_0001
Figure imgf000009_0001
2、 实验结果  2, the experimental results
通过采用二极管阵列检测器对供试品溶液在 190〜400 nm的紫外区进行 在线检测, 发现所得的色谱峰中主要是枳壳中的黄酮类成分以及乌药中的生 物碱类成分。乌药中去甲异波而定在 280nm波长下有最大吸收,枳壳中黄酮 类成分的紫外吸收行为极为相像,都在 283nm条件下的吸收最强,所提供的 信息量最丰富, 各峰的比例适合, 故综合选择 283nm作为检测波长。 On-line detection of the test solution in the ultraviolet region of 190~400 nm by using a diode array detector revealed that the obtained peaks were mainly flavonoids in the clam shell and the raw materials in the black peony. Alkaloids. In the black medicinal herb, the maximum absorption is at 280 nm. The ultraviolet absorption behavior of flavonoids in the oyster shell is very similar. The absorption is the strongest at 283 nm, and the information provided is the most abundant. The ratio is suitable, so a comprehensive selection of 283 nm is used as the detection wavelength.
实施例 2 色谱柱的优化  Example 2 Optimization of the column
1、 材料和方法  1, materials and methods
四磨汤制剂的供试品溶液同实施例 1。  The test solution of the Si Mo Tang preparation was the same as in Example 1.
高效液相色谱法检测: 色谱柱为 Venusil XBP-C18柱 (4.6mm X 250mm) 或 Agilent ZORBAX SB-C18柱(4.6mm X 250mm), 检测波长为 283nm, 其他 条件同实施例 1。 High performance liquid chromatography detection: The column was a Venusil XBP-C 18 column (4.6 mm X 250 mm) or an Agilent ZORBAX SB-C 18 column (4.6 mm X 250 mm) with a detection wavelength of 283 nm, and other conditions were the same as in Example 1.
2、 实验结果  2, the experimental results
采用 Venusil XBP-C18柱 (4.6mmX 250mm) 所得色谱图如图 1A所示, 采用 Agilent ZORBAX SB-C18柱 (4.6mmX 250mm) 所得色谱图如图 1B所 示。两者对比,采用 Venusil XBP-C18柱 ( 4.6mm X 250mm)柱进行色谱分离, 洗脱出的色谱峰更加平稳 (见图 1 ), 所以优选 Venusil XBP-C18柱 (4.6mm X 250mm) 柱。 The chromatogram obtained using a Venusil XBP-C 18 column (4.6 mm X 250 mm) is shown in Figure 1A, and the chromatogram obtained using an Agilent ZORBAX SB-C 18 column (4.6 mm X 250 mm) is shown in Figure 1B. In contrast, the Venusil XBP-C 18 column (4.6mm X 250mm) column is used for chromatographic separation, and the eluted peak is more stable (see Figure 1), so the Venusil XBP-C 18 column (4.6mm X 250mm) is preferred. column.
实施例 3 特征峰及参照峰的指认  Example 3 Identification of characteristic peaks and reference peaks
1、 材料和方法  1, materials and methods
四磨汤制剂的供试品溶液同实施例 1。  The test solution of the Si Mo Tang preparation was the same as in Example 1.
标准品的配制: 精密称取柚皮苷、 橙皮苷、 新橙皮苷、 异柚皮苷、 去甲 异波尔定、山梨酸钾适量,精密称定,加甲醇制成每 1毫升各含柚皮苷 lmg、 橙皮苷 25μ§、 新橙皮苷 0.45mg、 异柚皮苷 80μ§、 去甲异波而定 45μ§、 山梨 酸钾 0.2mg的溶液, 即得标准品。 Preparation of standard products: Accurately weigh naringin, hesperidin, neohesperidin, isophylloside, norbiphordine, potassium sorbate, accurately weighed, add methanol to make each 1 ml LMG containing naringin, hesperidin 25μ §, neohesperidin 0.45 mg, isonaringin 80μ §, methyl isobutyl wave set to 45μ §, potassium sorbate 0.2mg solution, that was the standard.
高效液相色谱法检测方法: 分别精密吸取标准品与供试品溶液各 5μ1, 分别注入高效液相色谱仪进行测定。色谱柱为 Venusil XBP-C18柱(4.6mm X 250mm) , 检测波长为 283nm, 其他条件同实施例 1。 2、 实验结果 High-performance liquid chromatography detection method: respectively, accurately extract the standard product and the test solution 5μ1, respectively, and inject them into high performance liquid chromatography for measurement. The column was a Venusil XBP-C 18 column (4.6 mm X 250 mm) with a detection wavelength of 283 nm, and other conditions were the same as in Example 1. 2, the experimental results
四磨汤口服液的供试品溶液和标准品的色谱图分别如图 2A和图 2B所 示。 其中, 2为去甲异波尔定(保留时间: 13.1min), 3为新北美圣草苷(保 留时间: 19.9 min), 4为异柚皮苷 (保留时间: 21.7 min), 5为柚皮苷 (保 留时间: 22.6 min), 6为橙皮苷 (保留时间: 23.2 min), 8为新橙皮苷 (保 留时间: 24.0 min), 10为山梨酸钾 (保留时间: 25.1 min)。  The chromatograms of the test solution and the standard of the Si Mo Tang Oral Liquid are shown in Fig. 2A and Fig. 2B, respectively. Among them, 2 is norbibelol (retention time: 13.1min), 3 is new North American ergoside (retention time: 19.9 min), 4 is isoquerment (retention time: 21.7 min), 5 is pomelo Decoction (retention time: 22.6 min), 6 is hesperidin (retention time: 23.2 min), 8 is neohesperidin (retention time: 24.0 min), and 10 is potassium sorbate (retention time: 25.1 min).
实施例 4 检测时间  Example 4 Detection time
1、 材料和方法  1, materials and methods
四磨汤制剂的供试品溶液同实施例 1。  The test solution of the Si Mo Tang preparation was the same as in Example 1.
高效液相色谱法检测方法: 检测时间为 70min, 其他条件同实施例 3。 High performance liquid chromatography detection method: The detection time was 70 min, and other conditions were the same as in Example 3.
2、 实验结果 2, the experimental results
记录 70min色谱峰, 40min后没有出峰, 提示 40min内四磨汤各成分出 峰完全。 因此, 选择 40〜50min的检测时间较合适。  The peak of 70 min was recorded, and there was no peak after 40 min, suggesting that the peaks of the four mills were completely within 40 min. Therefore, it is appropriate to select a detection time of 40 to 50 minutes.
实施例 5 洗脱条件  Example 5 Elution conditions
1、 不同梯度的本发明乙腈 -0.1 %的甲酸水溶液流动相条件  1. Different gradients of mobile phase conditions of the acetonitrile-0.1% formic acid aqueous solution of the invention
色谱柱为 Venusil XBP-C18柱 (4.6mmX 250mm) 柱, 流动相 A为乙腈, 流动相 B为体积百分比 0.1%的甲酸水溶液, 洗脱梯度如表 3-1、 3-2、 3-3和 3-4所示, 柱温为 30°C, 流速为 l.Oml min—1 , 检测波长为 283nm, 色谱图如 图 3A、 B、 C和 D所示。 The column is a Venusil XBP-C 18 column (4.6mmX 250mm) column, the mobile phase A is acetonitrile, and the mobile phase B is 0.1% by volume aqueous formic acid. The elution gradient is shown in Table 3-1, 3-2, 3-3. As shown in Figures 3-4, the column temperature is 30 ° C, the flow rate is 1.0 ml min -1 , the detection wavelength is 283 nm, and the chromatogram is shown in Figures 3A, B, C and D.
表 3-1  Table 3-1
Figure imgf000011_0001
Figure imgf000011_0001
表 3-2 时间 (分钟) 流动相 (v/v%) Table 3-2 Time (minutes) mobile phase (v/v%)
0至 5 10%流动相 A和 90%流动相 B  0 to 5 10% mobile phase A and 90% mobile phase B
5至 23 线性梯度改变至: 25%流动相 A和 75%流动相 B 5 to 23 linear gradient changes to: 25% mobile phase A and 75% mobile phase B
23至 35 线性梯度改变至: 92%流动相 A和 8%流动相 B23 to 35 linear gradient changes to: 92% mobile phase A and 8% mobile phase B
35至 45 92%流动相 A和 8%流动相 B 35 to 45 92% mobile phase A and 8% mobile phase B
表 3-3  Table 3-3
时间 (分钟) 流动相 (v/v%)  Time (minutes) mobile phase (v/v%)
0至 5 15%流动相 A和 85%流动相 B  0 to 5 15% mobile phase A and 85% mobile phase B
5至 20 线性梯度改变至: 40%流动相 A和 60%流动相 B 5 to 20 linear gradient changes to: 40% mobile phase A and 60% mobile phase B
20至 32 线性梯度改变至: 100%流动相 A和 0%流动相 B20 to 32 linear gradient changes to: 100% mobile phase A and 0% mobile phase B
32至 40 100%流动相 A和 0%流动相 B 32 to 40 100% mobile phase A and 0% mobile phase B
表 3-4  Table 3-4
Figure imgf000012_0001
Figure imgf000012_0001
由上述实验可见, 在本发明的洗脱条件下, 流动相的比例在一定范围内 变化时, 对分离度的影响较小, 各组分的相对出峰顺序较为一致, 该条件具 有一定的耐用性, 所以确定乙腈和 0.1%的甲酸系统更具方便性和实用性。  It can be seen from the above experiments that under the elution condition of the present invention, when the proportion of the mobile phase changes within a certain range, the influence on the resolution is small, and the relative peak order of each component is relatively uniform, and the condition has certain durability. Sex, so it is more convenient and practical to determine the acetonitrile and 0.1% formic acid system.
2、 对比流动相条件  2. Comparison of mobile phase conditions
色谱柱为 Venusil XBP-C18柱 (4.6mm X 250mm), 柱温为 30°C, 流速为 lmL-min"1, 检测波长 283nm。 The column was a Venusil XBP-C 18 column (4.6 mm X 250 mm) with a column temperature of 30 ° C, a flow rate of 1 mL-min" 1 , and a detection wavelength of 283 nm.
对比流动相及洗脱梯度: 以乙腈(流动相 A) -醋酸铵缓冲液(流动相 C) 为流动相, 醋酸铵缓冲液配制: 醋酸铵 1.5g+2ml冰醋酸 +1000ml水。 以表 4-1、 4-2、 4-3和 4-4所示的洗脱梯度进行洗脱, 色谱图分别如图 4A、 图 4B、 图 4C和图 4D所示。 Comparison of mobile phase and elution gradient: Prepare with acetonitrile (mobile phase A) - ammonium acetate buffer (mobile phase C) as mobile phase, ammonium acetate buffer: ammonium acetate 1.5g + 2ml glacial acetic acid + 1000ml water. Elution was performed using the elution gradients shown in Tables 4-1, 4-2, 4-3, and 4-4. The chromatograms are shown in Figure 4A and Figure 4B, respectively. Figures 4C and 4D are shown.
表 4-1  Table 4-1
Figure imgf000013_0001
Figure imgf000013_0001
如图 4中八、 B、 C和 D所示, 采用上述乙腈 -醋酸铵缓冲液为流动相, 色谱峰保留时间变化较大。 以山梨酸钾为例, 当梯度洗脱条件变化时, 其色 谱峰保留时间变化较大, 会和枳壳中的柚皮苷、 橙皮苷或新橙皮苷等成分的 色谱峰部分重叠或完全重叠。 因此, 采用该流动相建立的方法缺乏一定的耐 用性。 而且, 使用缓冲盐洗脱后, 对仪器和色谱柱的养护要求较高。  As shown in Fig. 4, B, C and D, the above-mentioned acetonitrile-ammonium acetate buffer was used as the mobile phase, and the retention time of the chromatographic peak changed greatly. Taking potassium sorbate as an example, when the gradient elution conditions change, the retention time of the chromatographic peak changes greatly, and it may partially overlap with the chromatographic peaks of naringin, hesperidin or neohesperidin in the clam shell or Completely overlapping. Therefore, the method established using this mobile phase lacks certain durability. Moreover, the instrument and column maintenance requirements are higher after elution with buffer salts.
实施例 6 流速和柱温对分离效果的影响  Example 6 Effect of Flow Rate and Column Temperature on Separation Effect
色谱柱为 Venusil XBP-C18柱 (4.6mmX 250mm) 柱, 流动相 A为乙腈, 流动相 B 为体积百分比 0.1%的甲酸水溶液, 按实施例 1 的洗脱梯度进行 HPLC分析。 流速和柱温, 以及保留时间、 对称因子、 分离度和理论塔板数 如表 5所; The column was a Venusil XBP-C 18 column (4.6 mm X 250 mm) column, mobile phase A was acetonitrile, and mobile phase B was a 0.1% by volume aqueous solution of formic acid. HPLC analysis was carried out according to the elution gradient of Example 1. Flow rate and column temperature, as well as retention time, symmetry factor, resolution and theoretical plate number As shown in Table 5;
表 5 table 5
Figure imgf000014_0001
Figure imgf000014_0001
由表 5可见, 流速和柱温对本发明方法的分离效果影响不大, 上述条件 均能获得较佳的分离效果。 It can be seen from Table 5 that the flow rate and column temperature have little effect on the separation effect of the method of the present invention, and the above conditions Both can achieve better separation results.
实施例 7 各种四磨汤制剂的前处理方法  Example 7 Pretreatment method of various four-mill soup preparations
( 1 ) 四磨汤片剂的前处理  (1) Pretreatment of Si Mo Tang Tablets
取 20片四磨汤片剂, 研钵研碎, 称取 2g置于 lOOmL容量瓶, 加 90mL 甲醇超声 30min溶解, 冷却后补加甲醇至刻度, 摇匀, 用 0.22μηι聚醚砜微 孔滤膜过滤, 滤液稀释 50倍即得供试品溶液。  Take 20 tablets of four-milled soup, grind it in a mortar, weigh 2g into a lOOmL volumetric flask, add 90mL of methanol to sonicate for 30min, add methanol to the mark after cooling, shake well, use 0.22μηι polyethersulfone microporous filter The membrane was filtered, and the filtrate was diluted 50 times to obtain a test solution.
(2 ) 四磨汤胶囊的前处理  (2) Pretreatment of Si Mo Tang Capsules
取 20粒四磨汤胶囊, 研钵研碎, 称取 2g置于 lOOmL容量瓶, 加 90mL 乙醇超声 30min溶解, 冷却后补加乙醇至刻度, 摇匀, 用 0.45μηι聚四氟乙 烯微孔滤膜过滤, 滤液稀释 60倍即得供试品溶液。  Take 20 capsules of Si Mo Tang, grind it in a mortar, weigh 2g into a lOOmL volumetric flask, add 90mL of ethanol to sonicate for 30min, then add ethanol to the scale after cooling, shake well, use 0.45μηι polytetrafluoroethylene microporous filter The membrane was filtered, and the filtrate was diluted 60 times to obtain a test solution.
(3 ) 四磨汤滴丸的前处理  (3) Pretreatment of Si Mo Tang Pills
取 20粒四磨汤滴丸, 研钵研碎, 称取 2g置于 lOOmL容量瓶, 加 90mL 体积比 60%甲醇水溶液超声 30min溶解,冷却后补加体积比 60%甲醇水溶液 至刻度, 摇匀, 用 0.80μηι醋酸纤维素微孔滤膜过滤, 滤液稀释 80倍即得供 试品溶液。  Take 20 tablets of Si Mo Tang Dropping Pills, grind it in a mortar, weigh 2g into a 100mL volumetric flask, add 90mL volume to 60% methanol aqueous solution for 30min, dissolve, add 60% methanol solution to the mark after cooling, shake well It was filtered through a 0.80 μηι cellulose acetate microporous membrane, and the filtrate was diluted 80 times to obtain a test solution.
(4 ) 四磨汤软胶囊的前处理  (4) Pretreatment of Si Mo Tang Soft Capsules
取 50粒四磨汤软胶囊, 取出内容物, 称取 2g内容物置于 lOOmL容量 瓶,加 90mL甲醇超声 30min溶解,冷却后补加甲醇至刻度,摇匀,用 0.45μηι 聚四氟乙烯微孔滤膜过滤, 滤液稀释 70倍即得供试品溶液。  Take 50 capsules of four-milled soft capsules, take out the contents, weigh 2g of content into a lOOmL volumetric flask, add 90mL of methanol for 30min to dissolve, add methanol to the mark after cooling, shake well, use 0.45μηι polytetrafluoroethylene microporous The membrane is filtered, and the filtrate is diluted 70 times to obtain a test solution.
( 5 ) 四磨汤颗粒的前处理  (5) Pretreatment of Si Mo Tang Granules
取 20包四磨汤颗粒,研钵研碎,称取 2g置于 lOOmL容量瓶,加 90mL70% 乙醇水溶液超声 30min溶解, 冷却后补加 70%乙醇水溶液至刻度, 摇匀, 用 0.45μηι聚偏氟乙烯微孔滤膜过滤, 滤液稀释 80倍即得供试品溶液。  Take 20 packets of Si Mo Tang granules, grind and grind, weigh 2g into a lOOmL volumetric flask, add 90mL 70% ethanol aqueous solution to sonicate for 30min, then add 70% ethanol solution to the mark after cooling, shake well, 0.45μηι The fluoroethylene microporous membrane was filtered, and the filtrate was diluted 80 times to obtain a test solution.
实施例 8 本发明四磨汤制剂的检测方法的方法学考察  Example 8 Methodological study on the detection method of the four-mill soup preparation of the present invention
下述实验的高效液相色谱法条件同实施例 3。  The high performance liquid chromatography conditions of the following experiment were the same as in Example 3.
1、 系统适应性试验 材料和方法同实施例 3。 该测定方法理论塔板数按柚皮苷计算不低于 3000。 1, system adaptability test Materials and methods were the same as in Example 3. The number of theoretical plates in the assay is not less than 3,000 based on naringin.
2、 标准曲线及线性范围  2, standard curve and linear range
取柚皮苷、 橙皮苷、 新橙皮苷、 异柚皮苷、 去甲异波尔定、 山梨酸钾适 量, 精密称定, 分别置不同的量瓶中, 加甲醇制成每 1ml 分别含柚皮苷 1.0164mg、 橙皮苷 0.2412mg、 新橙皮苷 0.9644mg、 异柚皮苷 0.4024mg、 去 甲异波尔定 0.4324mg、 山梨酸钾 2.5236mg的溶液, 摇匀, 即为储备液。 将 各溶液分别按表 6-1、 6-2、 6-3、 6-4、 6-5、 6-6中浓度稀释, HPLC检测, 进样量 5μ1, 数据见表 6-1〜6-2, 绘制标准曲线, 见表 7。  Take naringin, hesperidin, neohesperidin, isophylloside, norbiphordine, potassium sorbate, accurately weighed, set separately in different measuring flasks, add methanol to make each 1ml separately A solution containing 1.0164 mg of naringin, 0.2412 mg of hesperidin, 0.9644 mg of new hesperidin, 0.4024 mg of isoquertoside, 0.4324 mg of norbipoldine, and 2.5236 mg of potassium sorbate. Shake well. liquid. Each solution was diluted according to the concentrations in Tables 6-1, 6-2, 6-3, 6-4, 6-5, 6-6, and detected by HPLC. The injection volume was 5μ1. The data is shown in Table 6-1~6- 2. Draw a standard curve, see Table 7.
表 6-1 去甲异波尔定标准曲线数据
Figure imgf000016_0001
Table 6-1 Noisoprene standard curve data
Figure imgf000016_0001
表 6-2 异柚皮苷标准曲线数据  Table 6-2 Isophylline standard curve data
Figure imgf000016_0002
表 6-6 山梨酸钾标准曲线数据 C g/mL 1261.8 504.72 252.36 100.944 50.472 10.0944 5.0472 2.5326 0.6309
Figure imgf000016_0002
Table 6-6 K-sorbate standard curve data C g/mL 1261.8 504.72 252.36 100.944 50.472 10.0944 5.0472 2.5326 0.6309
A 20854.9 8781.7 4448.3 1802.8 954 183.4 92 45.5 11.68 各指标成分标准曲线和线性范围 A 20854.9 8781.7 4448.3 1802.8 954 183.4 92 45.5 11.68 Standard curve and linear range of each indicator component
Figure imgf000017_0001
Figure imgf000017_0001
3、 定量限 (LOQ) 和检测限 (LOD)  3. Limit of quantitation (LOQ) and limit of detection (LOD)
标准品 (去甲异波而定、 异柚皮苷、 柚皮苷、 橙皮苷、 新橙皮苷和山梨 酸钾) 进样浓度分别如表 8所示时, 信噪比 S/N=10或 3, 分别为上述各指 标成分的定量限和检测限。 各指标成分的定量限色谱图如图 5A和 5B所示。  The standard samples (norgosine, isophylloside, naringin, hesperidin, neohesperidin and potassium sorbate) are shown in Table 8. The signal-to-noise ratio S/N= 10 or 3, which are the limit of quantitation and detection limit of each of the above indicators. The quantitative limit chromatograms of the various indicator components are shown in Figures 5A and 5B.
表 8 各指标成分定量限 (LOQ) 和检测限 (LOD)  Table 8 Quantitative limits (LOQ) and detection limits (LOD) for each indicator
Figure imgf000017_0002
Figure imgf000017_0002
4、 精密度考察  4, precision inspection
分别取三种不同浓度的标准品溶液, 去甲异波尔定的浓度分别为 43.24 g/mL、 86.48 g/mL、 172.96 g/mL, 异柚皮苷的浓度分别为 40.24 g/mL、 80.48 g/mL、 402.4μ§/ηΛ, 柚皮苷的浓度分别为 101.64 g/mL、 203.3(Vg/mL、 1016.4 g/mL, 橙皮苷的浓度分别为 24.12 g/mL、 48.24 g/mL、 241.2 g/mL, 新 橙皮苷的浓度分别为 96.44 g/mL、 192.88 g/mL、 964.4 g/mL, 山梨酸钾浓度 分别为 50.472 g/mL、 252.36 g/mL、 504.72 g/mL, 进样量 5 L, 每组浓度重 复进样 6次, HPLC检测, 测定平均峰面积, 计算 RSD。 连续三天测试, 计 算 RSD, 结果如表 9和 10所示。 Three standard solutions of different concentrations were taken. The concentrations of norbipotrel were 43.24 g/mL, 86.48 g/mL, and 172.96 g/mL, respectively. The concentrations of isoquertoside were 40.24 g/mL and 80.48, respectively. g/mL, 402.4μ § /ηΛ, the concentration of naringin was 101.64 g/mL, 203.3 (Vg/mL, 1016.4 g/mL, the concentration of hesperidin was 24.12 g/mL, 48.24 g/mL, respectively. At 241.2 g/mL, the concentrations of neohesperidin were 96.44 g/mL, 192.88 g/mL, and 964.4 g/mL, respectively. The potassium sorbate concentrations were 50.472 g/mL, 252.36 g/mL, and 504.72 g/mL, respectively. The sample volume was 5 L, and the concentration of each group was repeated 6 times. HPLC detection, determination of the average peak area, calculation of RSD. Three consecutive days of testing, counting Calculate RSD, the results are shown in Tables 9 and 10.
表 9 日内精密度测定结果 (n=6)  Table 9 Intraday precision measurement results (n=6)
Figure imgf000018_0001
Figure imgf000018_0001
由表 9可见, 同一天测试, 各指标成分不同浓度组的 RSD均小于 3 %, 表明该测定方法日内精密度良好。  It can be seen from Table 9 that on the same day, the RSD of each concentration component of each indicator component is less than 3%, indicating that the precision of the measurement method is good within days.
表 10 日间精密度测定结果 (n=6) 峰面积平均值 峰面积平均值 峰面积平均值 指标成分 RSD % Table 10 Daytime precision measurement results (n=6) Peak area average peak area average peak area average indicator component RSD %
(第 1天) (第 2天) (第 3天)  (Day 1) (Day 2) (Day 3)
447.63 458.3 449.2 0.76 去甲异波尔定 923.60 939.1 901.6 1. 33  447.63 458.3 449.2 0.76 norbibeldine 923.60 939.1 901.6 1. 33
1858.85 1889.8 1861.7 1. 17 1858.85 1889.8 1861.7 1. 17
300.82 295.2 313.2 1.85 异柚皮苷 588.97 599.1 602.3 0.97 300.82 295.2 313.2 1.85 Isophylline 588.97 599.1 602.3 0.97
2976.03 3052.2 2969 2.57 2976.03 3052.2 2969 2.57
812.92 795.3 844.1 1.88 柚皮苷 1649.98 1677.2 1686.4 0.94 812.92 795.3 844.1 1.88 Naringin 1649.98 1677.2 1686.4 0.94
8157.45 7996 7675.1 2.17 8157.45 7996 7675.1 2.17
222.68 217.7 230.6 1.84 橙皮苷 437.28 444.4 446.7 0.93 222.68 217.7 230.6 1.84 Hesperidin 437.28 444.4 446.7 0.93
2217.87 2091.8 2196.7 2.15 2217.87 2091.8 2196.7 2.15
879.68 858.5 910.1 1.77 新橙皮苷 1769.98 1799.8 1810.4 0.96 879.68 858.5 910.1 1.77 New hesperidin 1769.98 1799.8 1810.4 0.96
9032.72 8979.8 9183.6 0.69 9032.72 8979.8 9183.6 0.69
962.02 961.9 989 1.36 山梨酸钾 4583.25 4489.1 4448.3 1.44 962.02 961.9 989 1.36 potassium sorbate 4583.25 4489.1 4448.3 1.44
9150.50 9419.6 9483.6 1.72
Figure imgf000019_0001
9150.50 9419.6 9483.6 1.72
Figure imgf000019_0001
表明该测定方法日间精密度良好。 This indicates that the measurement method has good daytime precision.
5、 样品稳定性  5, sample stability
取四磨汤口服液 (湖南汉森制药股份有限公司, 批号 090436), 按实施 例 1的方法制备供试品溶液, 进行 HPLC检测, 结果见表 11。  Take the Si Mo Tang Oral Liquid (Hunan Hansen Pharmaceutical Co., Ltd., batch number 090436), prepare the test solution according to the method of Example 1, and perform HPLC detection. The results are shown in Table 11.
表 11 稳定性测定结果 时间 (h) 0 4 6 8 15 18 24 RSD % 去甲异波尔定 538.1 505.2 537.8 539.8 512.9 547.8 537.9 2.97 异柚皮苷 776.8 745.7 776.7 779.5 752.9 784.7 764.7 1.91 柚皮苷 8003.7 7983.9 8023.2 8034.9 8057.1 8110.6 8029.1 0.51 橙皮苷 263 250.3 262.5 263.8 251.3 265.5 255.9 2.43 新橙皮苷 4236.3 4230.4 4250.9 4258.9 4266.4 4294.1 4258.4 0.49 山梨酸钾 20607.6 20653.5 20679.1 20743.3 20745.4 20472 20641.67 0.46 由表 11可见, 样品在 24h内稳定, RSD在 0.46%〜2.97%间。 Table 11 Stability measurement results Time (h) 0 4 6 8 15 18 24 RSD % norbiphorol 538.1 505.2 537.8 539.8 512.9 547.8 537.9 2.97 Isophylline 776.8 745.7 776.7 779.5 752.9 784.7 764.7 1.91 Naringin 8003.7 7983.9 8023.2 8034.9 8057.1 8110.6 8029.1 0.51 Hesperidin 263 250.3 262.5 263.8 251.3 265.5 255.9 2.43 Neohesperidin 4236.3 4230.4 4250.9 4258.9 4266.4 4294.1 4258.4 0.49 Potassium Sorbate 20607.6 20653.5 20679.1 20743.3 20745.4 20472 20641.67 0.46 As can be seen from Table 11, the sample is stable within 24 h, RSD is 0.46%~ 2.97%.
6、 重复性实验  6, repeatability experiment
取四磨汤口服液 (湖南汉森制药股份有限公司, 批号 090436), 按实施 例 1的方法制备 6份供试品溶液, 进行 HPLC检测, 结果见表 12。  Take Si Mo Tang Oral Liquid (Hunan Hansen Pharmaceutical Co., Ltd., batch number 090436), and prepare 6 samples for the test solution according to the method of Example 1, and perform HPLC detection. The results are shown in Table 12.
表 12 重复性测定结果  Table 12 Repeatability results
Figure imgf000020_0001
Figure imgf000020_0001
由表 12可见, 各指标成分 RSD为 0.24%〜2.36%, 说明该检测方法重复 性良好。  As can be seen from Table 12, the RSD of each indicator component is 0.24% to 2.36%, indicating that the detection method has good repeatability.
7、 加样回收实验  7, sample recovery experiment
精密称定标准品柚皮苷、橙皮苷、新橙皮苷、异柚皮苷、去甲异波尔定、 山梨酸钾适量,加甲醇制成每 1ml分别含柚皮苷 1.0164mg、橙皮苷 0.2412mg、 新橙皮苷 09644mg、 异柚皮苷 0.4024mg、 去甲异波尔定 0.432.4 mg、 山梨酸 钾 2.5236mg的溶液, 摇匀, 即为各自的储备液, 备用。 Precisely weighed the standard naringin, hesperidin, neohesperidin, isophylloside, norbiphordine, potassium sorbate, and added methanol to make 1.0164mg of naringin per orange. 0.2412 mg of dermatan, 90,864 mg of hesperidin, 0.4024 mg of isoquertoside, 0.432.4 mg of norbiphordine, sorbic acid Potassium 2.5236mg solution, shake well, that is, the respective stock solution, spare.
精密量取四磨汤口服液(湖南汉森制药股份有限公司, 批号 090436)适 量, 按实施例 1方法过滤预处理, 置于 25mL量瓶中。 针对每种指标成分, 分别加入上样供试品溶液中所含该指标成分量 100%的标准品, 加入甲醇至 刻度 10ml, 摇匀, 进行 HPLC测定, 按如下公式计算加样回收率, 结果见 表 13。  Precisely measure the appropriate amount of Si Mo Tang Oral Liquid (Hunan Hansen Pharmaceutical Co., Ltd., batch number 090436), filter the pretreatment according to the method of Example 1, and place it in a 25 mL volumetric flask. For each indicator component, add the standard sample containing 100% of the index component in the sample solution, add methanol to the mark 10ml, shake it, and perform HPLC measurement. Calculate the recovery rate according to the following formula. See Table 13.
加样回收率%= (测得量-供试品溶液所含指标成分的量) /实际加入量 χ ΐοο% 表 13-1 去甲异波尔定加样回收实验结果 Addition recovery rate %= (measured amount - the amount of the indicator component contained in the test solution) / actual addition amount χ ΐοο% Table 13-1 Sample test results of deisomethodazole
Figure imgf000021_0001
Figure imgf000021_0001
表 13-3 异柚皮苷加样回收实验结果 样品量 平均含量 加入量 测得量 回收率 平均回收率 RSDTable 13-3 Results of different naringenin sample recovery experiments Sample volume average content addition amount measurement amount recovery rate average recovery rate RSD
(mL) (mg/mL) (mg) (mg) (%) (%) (%) (mL) (mg/mL) (mg) (mg) (%) (%) (%)
1.006 2.0668 103.86  1.006 2.0668 103.86
1.006 2.0487 102.06  1.006 2.0487 102.06
1.006 1.9880 96.02  1.006 1.9880 96.02
10 0.1022 101.52 2.78  10 0.1022 101.52 2.78
1.006 2.0460 101.79  1.006 2.0460 101.79
1.006 2.0482 102.01  1.006 2.0482 102.01
1.006 2.0620 103.38  1.006 2.0620 103.38
表 13-4 橙皮苷加样回收实验结果  Table 13-4 Results of hesperidin recovery test
Figure imgf000022_0001
Figure imgf000022_0001
表 13-5 新橙皮苷加样回收实验结果  Table 13-5 Results of new hesperidin sample recovery test
Figure imgf000022_0002
Figure imgf000022_0002
表 13-6 山梨酸钾加样回收实验结果 样品量 平均含量 加入量 测得量 回收率 平均回收 RSDTable 13-6 Experimental results of potassium sorbate sample recovery Sample amount average content addition amount measured amount recovery rate average recovery RSD
(mL) (mg/mL) (mg) (mg) (%) 率(%) (%) (mL) (mg/mL) (mg) (mg) (%) rate (%) (%)
3.0283 6.0537 99.78  3.0283 6.0537 99.78
3.0283 6.0309 97.03  3.0283 6.0309 97.03
3.0283 6.0791 100.62  3.0283 6.0791 100.62
2.5 1.2128 99.27 1.41  2.5 1.2128 99.27 1.41
3.0283 6.0334 99.11  3.0283 6.0334 99.11
3.0283 6.0428 98.42  3.0283 6.0428 98.42
3.0283 6.0800 100.65  3.0283 6.0800 100.65
由表 13-1〜13-6可见, 针对各指标成分, 本发明的检测方法具有良好的 加样回收率。  As can be seen from Tables 13-1 to 13-6, the detection method of the present invention has a good sample recovery rate for each index component.
实施例 9 四磨汤制剂指紋图谱的构建 Example 9 Construction of Fingerprint of Si Mo Tang Preparation
取四磨汤口服液成品 26批, 按实施例 3的方法制备供试品溶液, 并进 行 HPLC检测, 色谱图如图 6A所示。 图 6B为四磨汤口服液指紋图谱。  The sample was prepared in 26 batches of Si Mo Tang Oral Liquid, and the test solution was prepared according to the method of Example 3, and subjected to HPLC detection. The chromatogram is shown in Fig. 6A. Fig. 6B is a fingerprint of the four-milling oral liquid.
特征指紋峰的选择: 根据 26批四磨汤口服液成品的测定结果, 以柚皮 苷标准品为参照峰, 分别从 20个特征指紋峰中鉴定了 9个特征指紋峰, 即 去甲异波尔定 (3号)、 新北美圣草苷(6号)、 异柚皮苷(7号)、 柚皮苷(8 号)、橙皮苷(9号)、新橙皮苷(11号)、 山梨酸钾(13号)、为川陈皮素(18 号) 和红橘素 (19号)。  Selection of characteristic fingerprint peaks: According to the determination results of 26 batches of Si Mo Tang oral liquid, with the naringin standard as the reference peak, 9 characteristic fingerprint peaks were identified from 20 characteristic fingerprint peaks, namely, the de-isolated wave Erding (No. 3), New North American Glycyrrhizin (No. 6), Isoflavone (No. 7), Naringin (No. 8), Hesperidin (No. 9), Neohesperidin (No. 11) Potassium sorbate (No. 13), Chuan Chenshen (No. 18) and Red Tangerine (No. 19).
指紋图谱检测标准的建立:采用国家药典委员会推荐的中药色谱指紋图 谱相似度评价系统软件的操作规范 (2004A 1.0版), 采用均值法, 将 26批 四磨汤口服液成品的实验数据导入, 经选峰, 设定匹配模式, 将色谱峰自动 匹配, 然后设定标准模板, 进行色谱峰差异性评价和整体相似度评价。 依据 26批样品结果,通过中药色谱指紋图谱相似度评价系统软件,生成四磨汤口 服液指紋图谱(图 6B)。 各样品色谱图与该指紋图谱相比较的相似度结果见 表 14。该指紋图谱中各特征峰的保留时间是以柚皮苷标准品为参照峰,其余 各峰与之相比而得的相对保留时间, 见表 15。  The establishment of fingerprint mapping standards: using the Chinese Pharmacopoeia Committee recommended traditional Chinese medicine chromatographic fingerprint similarity evaluation system software operating specifications (2004A 1.0 version), using the mean method, the experimental data of 26 batches of Si Mo Tang oral liquid products, through Select the peak, set the matching mode, automatically match the peaks, and then set the standard template for the peak difference evaluation and overall similarity evaluation. According to the results of 26 batches of samples, the fingerprint of the TCM Tangkou solution was generated by the chromatographic fingerprint similarity evaluation system software of Chinese medicine (Fig. 6B). The similarity results of the chromatograms of each sample compared with the fingerprint are shown in Table 14. The retention time of each characteristic peak in the fingerprint is based on the standard value of the naringin standard, and the relative retention times of the other peaks are shown in Table 15.
表 14 与共有模式比较的 26批样品的相似度评价 样品编号 批次 厂商 相似度Table 14 Similarity evaluation of 26 batches compared to the common mode Sample number batch vendor similarity
SI 070109 湖南汉森制药股份有限公司 1.000SI 070109 Hunan Hansen Pharmaceutical Co., Ltd. 1.000
S2 070419 湖南汉森制药股份有限公司 0.999S2 070419 Hunan Hansen Pharmaceutical Co., Ltd. 0.999
S3 070706 湖南汉森制药股份有限公司 0.998S3 070706 Hunan Hansen Pharmaceutical Co., Ltd. 0.998
S4 071017 湖南汉森制药股份有限公司 0.999S4 071017 Hunan Hansen Pharmaceutical Co., Ltd. 0.999
S5 080121 湖南汉森制药股份有限公司 1.000S5 080121 Hunan Hansen Pharmaceutical Co., Ltd. 1.000
S6 080421 湖南汉森制药股份有限公司 0.997S6 080421 Hunan Hansen Pharmaceutical Co., Ltd. 0.997
S7 080712 湖南汉森制药股份有限公司 0.998S7 080712 Hunan Hansen Pharmaceutical Co., Ltd. 0.998
S8 081036 湖南汉森制药股份有限公司 0.988S8 081036 Hunan Hansen Pharmaceutical Co., Ltd. 0.988
S9 090225 湖南汉森制药股份有限公司 0.992S9 090225 Hunan Hansen Pharmaceutical Co., Ltd. 0.992
S10 090628 湖南汉森制药股份有限公司 0.991S10 090628 Hunan Hansen Pharmaceutical Co., Ltd. 0.991
Sl l 091026 湖南汉森制药股份有限公司 0.997Sl l 091026 Hunan Hansen Pharmaceutical Co., Ltd. 0.997
S12 091243 湖南汉森制药股份有限公司 0.995S12 091243 Hunan Hansen Pharmaceutical Co., Ltd. 0.995
S13 090424 湖南汉森制药股份有限公司 0.998S13 090424 Hunan Hansen Pharmaceutical Co., Ltd. 0.998
S14 090425-1 湖南汉森制药股份有限公司 0.996S14 090425-1 Hunan Hansen Pharmaceutical Co., Ltd. 0.996
S15 090426-1 湖南汉森制药股份有限公司 0.988S15 090426-1 Hunan Hansen Pharmaceutical Co., Ltd. 0.988
S16 090435-1 湖南汉森制药股份有限公司 0.996S16 090435-1 Hunan Hansen Pharmaceutical Co., Ltd. 0.996
S17 090436-1 湖南汉森制药股份有限公司 0.998S17 090436-1 Hunan Hansen Pharmaceutical Co., Ltd. 0.998
S18 060311-2 湖南中达骛马制药有限责任公司 0.969S18 060311-2 Hunan Zhongda Yuma Pharmaceutical Co., Ltd. 0.969
S19 060601-2 湖南中达骛马制药有限责任公司 0.997S19 060601-2 Hunan Zhongda Yuma Pharmaceutical Co., Ltd. 0.997
S20 060905-2 湖南中达骛马制药有限责任公司 0.996S20 060905-2 Hunan Zhongda Yuma Pharmaceutical Co., Ltd. 0.996
S21 061203-2 湖南中达骛马制药有限责任公司 0.993S21 061203-2 Hunan Zhongda Yuma Pharmaceutical Co., Ltd. 0.993
S22 070308-2 湖南中达骛马制药有限责任公司 0.999S22 070308-2 Hunan Zhongda Yuma Pharmaceutical Co., Ltd. 0.999
S23 070624-2 湖南中达骛马制药有限责任公司 0.994S23 070624-2 Hunan Zhongda Yuma Pharmaceutical Co., Ltd. 0.994
S24 070918-2 湖南中达骛马制药有限责任公司 0.997S24 070918-2 Hunan Zhongda Yuma Pharmaceutical Co., Ltd. 0.997
S25 071201-2 湖南中达骛马制药有限责任公司 0.995S25 071201-2 Hunan Zhongda Yuma Pharmaceutical Co., Ltd. 0.995
S26 080306-2 湖南中达骛马制药有限责任公司 0.999 根据以上试验结果, 并结合中药指紋图谱研究技术要求, 拟定符合下述 标准的四磨汤制剂为符合质量标准的制剂: 供试品溶液色谱图中各色谱峰应 与四磨汤口服液指紋图谱各特征峰一致, 相似度不低于 0.90。 表 15 四磨汤多指标指紋图谱中各特征峰的相对保留时间表 (分钟) S26 080306-2 Hunan Zhongda Yuma Pharmaceutical Co., Ltd. 0.999 Based on the above test results, combined with the technical requirements of traditional Chinese medicine fingerprints, the preparation of the four-mill soup preparations meeting the following standards is a preparation that meets the quality standards: The chromatographic peaks in the figure should be consistent with the characteristic peaks of the fingerprint of Si Mo Tang Oral Liquid, and the similarity is not less than 0.90. Table 15 Relative retention schedule of each characteristic peak in the multi-index fingerprint of Si Mo Tang (minutes)
Figure imgf000025_0001
Figure imgf000025_0001

Claims

权利要求 Rights request
1、 一种四磨汤制剂多指标成分同时测定方法, 其特征在于其包括如下 歩骤: 将四磨汤制剂的供试品溶液进行高效液相色谱法检测, 即可; 所述的 高效液相色谱法的色谱条件为: 色谱柱为十八垸基硅垸键合硅胶柱, 流动相 A为乙腈, 流动相 B为体积百分比 0.1%的甲酸水溶液, 洗脱梯度如表 1所 表 1 A method for simultaneously determining a multi-indicator component of a four-mill soup preparation, characterized in that it comprises the following steps: the test solution of the Si Mo Tang preparation is subjected to high performance liquid chromatography, and the high-efficiency liquid is used; The chromatographic conditions of the chromatographic method are as follows: the column is an 18-inch silicon germanium bonded silica gel column, the mobile phase A is acetonitrile, and the mobile phase B is 0.1% by volume aqueous formic acid. The elution gradient is shown in Table 1
Figure imgf000026_0001
Figure imgf000026_0001
检测波长为 283nm。  The detection wavelength was 283 nm.
2、 如权利要求 1所述的方法, 其特征在于: 所述的四磨汤制剂主要由 下述重量份数的原药材制得: 100份木香、 50〜150份枳壳、 50〜150份乌药 和 50〜150份槟榔。  2. The method according to claim 1, wherein: the preparation of the four-mill soup is mainly prepared from the following parts by weight of the original medicine: 100 parts of woody, 50 to 150 parts of clam shell, 50 to 150 A portion of black medicine and 50 to 150 parts of areca.
3、 如权利要求 2所述的方法, 其特征在于: 所述的四磨汤制剂为由下 述方法制得的四磨汤制剂: 将原药材经水蒸气蒸馏法提取的挥发性成分, 与 药渣经水提醇沉提取的水提物,按现有常规方法制成口服液、滴丸、乳化剂、 胶囊、 片剂或颗粒剂。  3. The method according to claim 2, wherein: the Si Mo Tang preparation is a Si Mo Tang preparation prepared by the following method: a volatile component extracted by steam distillation of the original medicine, and The aqueous extract of the dregs extracted by water extraction and alcohol precipitation is prepared into an oral liquid, a dropping pill, an emulsifier, a capsule, a tablet or a granule according to a conventional method.
4、 如权利要求 1所述的方法, 其特征在于: 所述的四磨汤制剂的供试 品溶液按下述方法制得:  4. The method according to claim 1, wherein: the test solution of the tetrabred soup preparation is prepared as follows:
当所述的四磨汤制剂为四磨汤口服液时,直接将四磨汤口服液用微孔滤 膜过滤, 滤液不经稀释, 或经稀释至原体积 100倍以下, 即为供试品溶液; 当所述的四磨汤制剂为除四磨汤口服液外的其他剂型时,将溶有四磨汤 制剂的溶液经超声处理,冷却,之后用微孔滤膜过滤,滤液即为供试品溶液。 When the said Si Mo Tang preparation is Si Mo Tang Oral Liquid, the Si Mo Tang Oral Liquid is directly filtered through a microporous membrane, and the filtrate is diluted or diluted to 100 times or less of the original volume, which is a test sample. Solution When the preparation of the Si Mo Tang preparation is other than the Si Mo Tang oral liquid, the solution in which the Si Mo Tang preparation is dissolved is sonicated, cooled, and then filtered through a microporous membrane, and the filtrate is used as a test sample. Solution.
5、 如权利要求 1所述的方法, 其特征在于: 所述的高效液相色谱法检 测的进样量为 2〜50μΙ^, 较佳的为 5〜20μΙ^。  The method according to claim 1, wherein the high-performance liquid chromatography detects an injection amount of 2 to 50 μM, preferably 5 to 20 μM.
6、 如权利要求 1所述的方法, 其特征在于: 所述的高效液相色谱法检 测的柱温为 15〜50°C, 较佳的为 20〜40°C ; 和 /或, 所述的高效液相色谱法检 测的流速为 0.5〜1.5 mL/ min, 较佳的为 0.8〜1.2mL/ min。  6. The method according to claim 1, wherein: the column temperature detected by the high performance liquid chromatography is 15 to 50 ° C, preferably 20 to 40 ° C; and/or, The flow rate detected by high performance liquid chromatography is 0.5 to 1.5 mL/min, preferably 0.8 to 1.2 mL/min.
7、 如权利要求 1或 6所述的方法, 其特征在于: 所述的十八垸基硅垸 键合硅胶柱为 Venusil XBP-C18柱或 Agilent ZORBAX SB-C18柱。 7. The method according to claim 1 or 6, wherein the octadecyl silicon germanium bonded silica gel column is a Venusil XBP-C 18 column or an Agilent ZORBAX SB-C 18 column.
8、 如权利要求 7所述的方法, 其特征在于: 所述的十八垸基硅垸键合 硅胶柱的径长规格为 4.6mm X 250mm或 4.6mm X 150mm。  8. The method according to claim 7, wherein: the octadecylsilicone-bonded silica gel column has a diameter of 4.6 mm X 250 mm or 4.6 mm X 150 mm.
9、如权利要求 7或 8所述的方法, 其特征在于: 所述的洗脱梯度如表 2 所示;  The method according to claim 7 or 8, wherein: the elution gradient is as shown in Table 2;
表 2  Table 2
Figure imgf000027_0001
Figure imgf000027_0001
10、一种四磨汤制剂指紋图谱的构建方法,其特征在于其包括如下歩骤: 采用如权利要求 1〜9任一项所述的方法检测四磨汤制剂,再采用中药色谱指 紋图谱相似度评价系统软件, 模拟生成四磨汤制剂指紋图谱。  A method for constructing a fingerprint of a four-milled soup preparation, characterized in that it comprises the following steps: using the method according to any one of claims 1 to 9 to detect a preparation of a Si Mo Tang, and then using a chromatographic fingerprint similar to a traditional Chinese medicine; The evaluation system software simulates the fingerprint of the four-mill soup preparation.
PCT/CN2011/075808 2011-03-25 2011-06-16 Methods for simultaneously determinating multi-component of simotang and fingerprint building method thereof WO2012129847A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2011100745487A CN102221590B (en) 2011-03-25 2011-03-25 Method for simultaneously determining multi-index ingredients of Simotang preparation and establishing fingerprint chromatogram thereof
CN201110074548.7 2011-03-25

Publications (1)

Publication Number Publication Date
WO2012129847A1 true WO2012129847A1 (en) 2012-10-04

Family

ID=44778198

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2011/075808 WO2012129847A1 (en) 2011-03-25 2011-06-16 Methods for simultaneously determinating multi-component of simotang and fingerprint building method thereof

Country Status (2)

Country Link
CN (1) CN102221590B (en)
WO (1) WO2012129847A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016094462A1 (en) 2014-12-09 2016-06-16 Oms Investments, Inc. Urea fertilizer compositions comprising rice hulls and methods of use

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103884676B (en) * 2014-02-27 2016-06-22 浙江大学 A kind of rapid assay methods of Chinese crude drug multi-target ingredient content
CN103808848A (en) * 2014-03-01 2014-05-21 张家港威胜生物医药有限公司 High-performance liquid chromatography for detecting content of neosperidin dihydrochalcone
CN104459003B (en) * 2014-12-16 2016-01-20 湖南汉森制药股份有限公司 The construction method of contracting spring standard preparation finger-print and characteristic spectrum and quality determining method
CN105301158A (en) * 2015-10-22 2016-02-03 湖南汉森制药股份有限公司 Fingerprint spectrum determination method for Simotang oral solution
CN110327451A (en) * 2018-12-19 2019-10-15 吉林修正药业新药开发有限公司 The Chinese medicine composition and preparation method thereof for treating anemofrigid cold
CN111450185B (en) * 2020-05-14 2021-07-20 湖南汉森制药股份有限公司 Simotang soft capsule and preparation method thereof
CN114062553B (en) * 2021-11-17 2024-05-07 荣昌制药(淄博)有限公司 HPLC fingerprint determination method of children six-ingredient food-enhancing ointment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040035359A (en) * 2002-10-22 2004-04-29 주식회사 엘지생활건강 Method of quantitatively analyzing polyethoxlyated ascorbic acid by using high performance liquid chromatograhpy
CN1566942A (en) * 2003-06-26 2005-01-19 中国科学院过程工程研究所 Method for drafting traditional Chinese medicinal spectrum by employing high-speed reverse-flow chromatogram
CN1843445A (en) * 2006-02-10 2006-10-11 童玉新 Traditional Chinese medicine drop pill and its preparation method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040035359A (en) * 2002-10-22 2004-04-29 주식회사 엘지생활건강 Method of quantitatively analyzing polyethoxlyated ascorbic acid by using high performance liquid chromatograhpy
CN1566942A (en) * 2003-06-26 2005-01-19 中国科学院过程工程研究所 Method for drafting traditional Chinese medicinal spectrum by employing high-speed reverse-flow chromatogram
CN1843445A (en) * 2006-02-10 2006-10-11 童玉新 Traditional Chinese medicine drop pill and its preparation method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016094462A1 (en) 2014-12-09 2016-06-16 Oms Investments, Inc. Urea fertilizer compositions comprising rice hulls and methods of use
US9663412B2 (en) 2014-12-09 2017-05-30 Oms Investments, Inc. Urea fertilizer compositions comprising rice hulls and methods of use
US10822290B2 (en) 2014-12-09 2020-11-03 Oms Investments, Inc. Urea fertilizer compositions comprising rice hulls and methods of use

Also Published As

Publication number Publication date
CN102221590A (en) 2011-10-19
CN102221590B (en) 2013-06-12

Similar Documents

Publication Publication Date Title
WO2012129847A1 (en) Methods for simultaneously determinating multi-component of simotang and fingerprint building method thereof
CN103163260B (en) Determination method of fingerprints of drugs
CN103197027A (en) Quality control method of astragalus-leech capsules capable of regulating collaterals
WO2012155376A1 (en) Method for detecting simotang preparation
CN104013710A (en) Gardenia-cortex phellodendri composition and detection method thereof
CN105301168B (en) The detection method of dredging collateral resolving sputum capsule
CN103197026A (en) Quality control method of granules capable of strengthening and consolidating body resistance
CN102218122A (en) Quality control and detection method for sea dragon and gecko oral liquid
CN102068627A (en) Quality control method for Chinese medicine preparation Xinnaojing tabelets
CN102068598A (en) Quality control method of Yangrong Baicao Wan for treating irregular menses caused by hemophthisis
CN104833754B (en) A kind of attached sweet drug detection method
CN104069200A (en) &#34;Sanhuang&#34; heart-fire removing decoction formula granules and preparing method and detection method thereof
CN113759056B (en) Characteristic spectrum of Chinese lobelia and preparation thereof and construction method thereof
CN102830198A (en) Method for detecting mulberry formula particles
CN102590423B (en) Fingerprint spectrum determination method of ligusticum wallichii tea-blending granular preparation
CN113820422B (en) Fingerprint detection method for total glucosides of white paeony
CN114942291A (en) Method for detecting quality of &#39;Zhenyang Yangyin&#39; granule
CN107607653A (en) The method for determining Radix Scrophulariae extract finger-print
CN103267824A (en) Method for detecting wind-cold cold granules
CN113655166A (en) High performance liquid detection method for 14 components in golden flower refreshing granules
CN101936974B (en) Method for identifying Chinese patent drugs by using mixed contrast
CN105004833A (en) Detection method for traditional Chinese medicine preparation for treating acute gouty arthritis and gout
CN104820055B (en) A kind of discrimination method of attached sweet medicine
CN106323794B (en) Method for detecting process stability of gallbladder warming tablets
CN103923138A (en) Preparation method and application of nicotiflorin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11862483

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11862483

Country of ref document: EP

Kind code of ref document: A1